RAPID RESPONSES

Think of Rapid Responses as electronic letters to the editor.

To RESPOND to a particular article: Click on the link 'Respond to this article' in the box at the top left hand corner of the article.

To READ responses to a particular article: Click on the link 'Read responses to this article' in the box at the top left hand corner of the article.

All responses published in the past 3 days are shown below. You can also read responses published in the past 2, 3, 4, 5, 6, 7, 14, or 21 days.


Rapid Responses published in the past 3 days:

53 Rapid Responses published for 33 different articles.

Articles    Rapid Responses
Jump to Rapid Responses for citation
RESEARCH:
Effectiveness of paramedic practitioners in attending 999 calls from elderly people in the community: cluster randomised controlled trial
Mason et al. (4 October 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Older people who fall are more likely to fall again
Philippa A Logan, et al.   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Amateur boxing and risk of chronic traumatic brain injury: systematic review of observational studies
Loosemore et al. (4 October 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Amateur boxing
Simon M. Kemp   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
VIEWS & REVIEWS:
Why the culture of medicine has to change
Hayward (13 October 2007) [Full text] [PDF]
Jump to Rapid Response Re: Change yes......but incrementally!
Sam Lewis   (13 October 2007)
Jump to Rapid Response Change yes......but incrementally!
peter j mahaffey   (13 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
PRACTICE:
An unusual cause of jaundice
Owen et al. (13 October 2007) [Full text] [PDF]
Jump to Rapid Response A Manifestation of Gilbert's Syndrome?
Ossie F Uzoigwe   (13 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS)
James et al. (13 October 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Too early to ditch the fizz campaign
J. Lennert Veerman, et al.   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality
Westaby et al. (13 October 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Public reporting of Outcomes in Surgery: Time to reflect on Bristol?
Ashok I Handa   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
FEATURE:
From small things
Reynolds (13 October 2007) [Full text] [PDF]
Jump to Rapid Response Chemical toxicity and mitochondria
Heikki Savolainen   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
NEWS:
Mother asks surgeons to perform hysterectomy on daughter with cerebral palsy
Dyer (13 October 2007) [Full text]
Jump to Rapid Response Hysterectomy/Sterilisation
Vaidyanathan Gowri   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
NEWS:
Tooke inquiry calls for major overhaul of specialist training
Eaton (13 October 2007) [Full text] [PDF]
Jump to Rapid Response Post-CCT "Specialist" !
Stuart H McClelland   (13 October 2007)
Jump to Rapid Response Re: Tooke report
D B Double   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITORIALS:
Modernising Medical Careers laid bare
Delamothe (13 October 2007) [Full text] [PDF]
Jump to Rapid Response ST Depression or ST Elevation?
Chika Uzoigwe, et al.   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITORIALS:
Screening for abdominal aortic aneurysm
Greenhalgh and Powell (13 October 2007) [Full text] [PDF]
Jump to Rapid Response Screening for abdominal aortic aneurysm
Hisato Takagi, et al.   (13 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITORIALS:
Participation in mammography screening
Schwartz and Woloshin (13 October 2007) [Full text] [PDF]
Jump to Rapid Response False positives don´t result in overdiagnosis
Christian Weymayr   (13 October 2007)
Jump to Rapid Response And Women Over 70, over 80?
Joseph More   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITOR'S CHOICE:
The way of the world
Delamothe (13 October 2007) [Full text]
Jump to Rapid Response What doctors should tell their patients about CAM
Roger A Fisken   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review
Pewsner et al. (6 October 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Left ventricular hypertrophy and QT dispersion in hypertensive patients
Antoni Sisó Almirall, et al.   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
ANALYSIS:
Adding fluoride to water supplies
Cheng et al. (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Fluoridation and aluminium
Christopher Exley   (13 October 2007)
Jump to Rapid Response A question of the common good
C Albert Yeung   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
OBSERVATIONS:
An age old problem
Richards (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Self Management :An age old solution to an age old problem
Arun K Chopra   (13 October 2007)
Jump to Rapid Response Right to die?
Peter Bruggen   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
FEATURE:
Should general practitioners resume 24 hour responsibility for their patients? Yes
Jones (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Not either or...
Steven Ford   (13 October 2007)
Jump to Rapid Response GP Land
Dr. Raja Baber Sheraz   (13 October 2007)
Jump to Rapid Response In support of the GP Co-op
john m caine   (12 October 2007)
Jump to Rapid Response 24hour responsibility
ravinder Norman   (11 October 2007)
Jump to Rapid Response depends on format
Duran Kandhai   (11 October 2007)
Jump to Rapid Response 24 hours
Gregory M Read   (11 October 2007)
Jump to Rapid Response Not keen!
Rosemary B Martin   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
FEATURE:
Industry funded patient information and the slippery slope to New Zealand
Toop and Mangin (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Anecdotal instance of positive effects of drug advertising
Charles L. Rogerson   (13 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
NEWS:
UK does well on giving information to patients but poorly on access to new treatments
Watson (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Bismark v. Beveridge
Iain S Fraser   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
NEWS:
Africans die in pain because of fears of opiate addiction
Logie and Leng (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Opiates for pain in dying patients and in those with sickle cell disease
Felix ID Konotey-Ahulu   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
LETTERS:
A cheap soundbite
Magos et al. (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Cold hands warm heart
Karen J Hebert   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITORIALS:
Reform of the coroner system and death certification
Luce (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Unintended consequences
Laurie R Davis   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITORIALS:
Encouraging children and adolescents to be more active
Giles-Corti and Salmon (6 October 2007) [Full text] [PDF]
Jump to Rapid Response Working harder together to tackle obesity
Shalini Pooransingh   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
VIEWS & REVIEWS:
MTAS or a tale of evidence heedless medicine
Nachev (22 September 2007) [Full text] [PDF]
Jump to Rapid Response Selection methodology: more fiction than fact, and a worrying future
A Thomson   (12 October 2007)
Jump to Rapid Response Unsatisfactory response by Ms Patterson
Peter von Kaehne   (12 October 2007)
Jump to Rapid Response No defence
ben dean   (11 October 2007)
Jump to Rapid Response Evidence heedless medicine
John Sanderson   (11 October 2007)
Jump to Rapid Response Re: Selection methodology; fact, fiction and the future
Alison L Gill   (11 October 2007)
Jump to Rapid Response Re: Selection methodology; fact, fiction and the future
Matthew J Daniels   (11 October 2007)
Jump to Rapid Response Re: MTAS or a tale of evidence heedless medicine
Alison S Carr   (11 October 2007)
Jump to Rapid Response More light less heat
Frank R Smith   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
PRACTICE:
Do all fractures need full immobilisation?
Glasziou (22 September 2007) [Full text] [PDF]
Jump to Rapid Response Appropriate, no universal, referal please
Paul P Glasziou   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
PRACTICE:
Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control
Barnes (8 September 2007) [Full text] [PDF]
Jump to Rapid Response A SMART choice for primary care asthma therapy ?
Brian J Lipworth, et al.   (13 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
CLINICAL REVIEW:
Acute respiratory distress syndrome
Leaver and Evans (25 August 2007) [Full text] [PDF]
Jump to Rapid Response Should we use low tidal volume in all our ARDS patients?
Eduardo M Svoren, et al.   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial
Montini et al. (25 August 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Response to Montini Article
Alejandro Hoberman, et al.   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
FEATURE:
Hyperactivity in children: the Gillberg affair
Gornall (25 August 2007) [Full text] [PDF]
Jump to Rapid Response Assessment for the Swedish Research Council
Denny H Vågerö   (12 October 2007)
Jump to Rapid Response Industry of Death?
Vanna Beckman   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
FEATURE:
Should we consider a boycott of Israeli academic institutions? No
Baum (21 July 2007) [Full text] [PDF]
Jump to Rapid Response Professor Baum still not answering and handing over to IMA
Christopher J Burns-Cox, et al.   (12 October 2007)
Jump to Rapid Response Professor Baum, as a Doctor: please treat the cause not the symptom
Mamdouh EL-Adl   (12 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Implementing the NHS information technology programme: qualitative study of progress in acute trusts
Hendy et al. (30 June 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Unexpected benefit of Choose and Book
Paul E Shannon   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
EDITORIALS:
Diabetic ketoacidosis
Dhatariya (23 June 2007) [Full text] [PDF]
Jump to Rapid Response Would Normal Saline be licensed today?
Nicholas Levy, et al.   (11 October 2007)
 Read every Rapid Response to this article

Jump to Rapid Responses for citation
RESEARCH:
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials
Walter et al. (10 March 2007) [Abstract] [Full text] [PDF]
Jump to Rapid Response Importance of calculation of absorbed dose in radioiodine treatment in patients pre-treated with antithyroid drugs
Gertrud Berg   (12 October 2007)
 Read every Rapid Response to this article
RESEARCH:
Effectiveness of paramedic practitioners in attending 999 calls from elderly people in the community: cluster randomised controlled trial
Mason et al. (4 October 2007) [Abstract] [Full text] [PDF]
Effectiveness of paramedic practitioners in attending 999 calls from elderly people...
Older people who fall are more likely to fall again
11 October 2007
 Next Rapid Response Top
Philippa A Logan,
Research Occupational Therapist
University of Nottingham, NG7 2UH,
John RF. Gladman, Kate Robertson

Send response to journal:
Re: Older people who fall are more likely to fall again

Whilst we welcome the development of services that improve satisfaction and which reduce unnecessary visits to Emergency Departments (ED), if falls are common, and falls prevention is possible, then being seen by a paramedic instead of ED or being referred to falls prevention teams means that these fallers may not get into evidence based services, such as demonstrated in the PROFET (Close et al., 1999) study, which picked up fallers from the ED. Thus, patients may be satisfied, the ED may be cleared, but preventable falls may still continue to occur and the old people affected may be unaware that there are effective interventions they are being denied. In collaboration with our local rehabilitation and ambulance services, we are evaluating in a RCT the application of falls prevention to this group of patients who fall, call an ambulance but who are not transported to hospital.

Close, J., Ellis, M., Hooper, R., Glucksman, E., Jackson, S., & Swift, C. (1999). Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. The Lancet, 353(9147), 93-97.

Competing interests: None declared

RESEARCH:
Amateur boxing and risk of chronic traumatic brain injury: systematic review of observational studies
Loosemore et al. (4 October 2007) [Abstract] [Full text] [PDF]
Amateur boxing and risk of chronic traumatic brain injury: systematic review of...
Amateur boxing
12 October 2007
Previous Rapid Response Next Rapid Response Top
Simon M. Kemp,
Sports Coach
PO10 7TX

Send response to journal:
Re: Amateur boxing

Between 1990 - 1994 it was my pleasure and privilege to coach the England Universities' Amateur Boxing squad. The team I took up to Scotland for an International match in November 1993 contained two Medical Students and was Captained by Alex Mehta MA (Oxon) who was then reading for a PhD in Environmental Law at Oriel College, Oxford University.

The British Medical Association has argued that young people under the "Age of Consent" should not be allowed to Box because they may be too young to understand the risks involved in participation in this tough combat sport.

Presumably the BMA would accept that someone studying Medicine at Cambridge or Oxford was old enough, and sufficiently well informed, to understand the risks involved in Boxing? Dr. Alex Mehta, winner of four Oxford University Boxing "Blues", is now a successful Barrister-at-Law. Hard to reconcile that record of intellectual achievement with the BMA's claims that "Boxing is bad for the brain."

Competing interests: Qualified Amateur Boxing Association Coach

VIEWS & REVIEWS:
Why the culture of medicine has to change
Hayward (13 October 2007) [Full text] [PDF]
Why the culture of medicine has to change
Re: Change yes......but incrementally!
13 October 2007
Previous Rapid Response Next Rapid Response Top
Sam Lewis,
GP
Surgery, Newport, Pembrokeshire, SA42 0TJ

Send response to journal:
Re: Re: Change yes......but incrementally!

I am busy writing a short piece for my 'Policy Analysis' course, contrasting the 'rationalistic' with the 'incrementalist' approach to decision-making... and then you come along , Richard, with a proposal that takes my breath away with its rational and incremental simplicity :-

[ask the clinicians] "Look, what do you need to get your waiting lists down to a managable length?" - they would have done it, and at a cost of one hundredth of what has been spent

Wow !! Didn't Gerry Robinson ask exactly that ? and didn't he hit a wall ??

so tell me Richard, how is it done ??

Competing interests: a doctor and a taxpayer

Why the culture of medicine has to change
Change yes......but incrementally!
13 October 2007
Previous Rapid Response Next Rapid Response Top
peter j mahaffey,
consultant plastic & reconstructive surgeon
bedford hospital

Send response to journal:
Re: Change yes......but incrementally!

Any analysis of the present woes of the UK medical profession from a working clinician (rather than medical or government politician) is a breath of fresh air in an environment where most of us seem to have been cowed into submission. And Richard Hayward is absolutely right to focus on what it is that spurs a doctor to enjoy his or her daily work....to solve a problem by using one's skills, with beneficial fall-out for patient, doctor and health service.

But after that, his analysis breaks down. The stimulus for the massive changes in our NHS were 'local' (getting down waiting lists etc) and 'big-picture', ie grappling with the spiralling health costs which have afflicted all nations. But the problem was not 'the culture of medicine' which, as Hayward defined, is about the self-gratification involved in diagnosis and treatment. Rather, it was the government of the day's error in inflicting repeated, wholesale, brutal changes to a complex ecosystem which had evolved over 60 yrs since 1947. No system could ever have withstood such an upheaval. All that was really needed was for wise government to make progressive nudges to the tiller. For better or worse, clinicians are far and away the best educated section of the NHS workforce. If someone had simply come to them and said "Look, what do you need to get your waiting lists down to a managable length?" they would have done it, and at a cost of one hundredth of what has been spent in the past 10 years. Moreover, doctors mostly also enjoy efficiency, and a similar direct appeal to them to 'help us get our budgets down for the good of us all' would very likely also have appealed to those self-same qualities.

But now the damage wrought by those seeking to weaken the profession is too great. And we are almost in the end-game where the politicians need only to wrest the last powerful card from our hand, the doctor-patient relationship. Infection crises, generic referrals, clinical guidelines, repeated 'fat-cat' allegations.... and soon we will be fully fledged state employees just as in Scandinavia! And then perhaps the state will realise that it wasn't the 'culture of medicine' that lost it the priceless asset of an independent profession.

Competing interests: None declared

PRACTICE:
An unusual cause of jaundice
Owen et al. (13 October 2007) [Full text] [PDF]
An unusual cause of jaundice
A Manifestation of Gilbert's Syndrome?
13 October 2007
Previous Rapid Response Next Rapid Response Top
Ossie F Uzoigwe,
Student
University of Leeds

Send response to journal:
Re: A Manifestation of Gilbert's Syndrome?

Dear Editor,

Icterus in the context of thyrotoxicosis is an interesting phenomenon. Given that jaundice is such a rare feature of hyperthyroidism it is unlikely that there exists a direct causal link. It is more probable that there is an underlying hepatic dysfunction which is unmasked and potentially exacerbated by the thyrotoxic state1. The most likely cause is Gilbert’s syndrome. Its prevalence may be as high as 12.4% in Caucasian men2. The disease is generally latent but becomes evident during times of illness. In the present case it is worth considering this possibility.

If the true mechanism was thyroxine-induced oxidative damage, one would suspect considerable hepatocellular injury with a significant irreversible element if the bilirubin rose to levels of 581umol/l, as in the instant case. Indeed 300umol/l is the threshold for liver transplantation in cases of paracetamol overdose. This is notable given that oxidative stress is also the mechanism of paracetamol’s hepatotoxicity3. Such injury would not be consistent with such a radical recovery. The rapid resolution of symptoms, seen in this case, once euthyroidism was established would be classical of the Gilbert’s syndrome.

1. Greenberger NJ, Milligan FD, Degroot LJ, Isselbacher KJ. Jaundice and thyrotoxicosis in the absence of congestive cardiac failure. Am J Med. 1964; 36:840-6.

2. Sieg A, Arab L, Schlierf G, Stiehl A, Kommerell B. Prevalence of Gilbert's syndrome in Germany. Dtsch Med Wochenschr. 1987 31;112:1206-8.

3. Jaeschke H, Knight TR, Bajt ML. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Lett. 2003; 144:279-88.

Competing interests: None declared

RESEARCH:
Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS)
James et al. (13 October 2007) [Abstract] [Full text] [PDF]
Preventing childhood obesity: two year follow-up results from the Christchurch obesity...
Too early to ditch the fizz campaign
11 October 2007
Previous Rapid Response Next Rapid Response Top
J. Lennert Veerman,
Research Fellow
UQ School of Population Health, Herston Road, Herston, QLD 4030, Australia,
Jan J. Barendregt

Send response to journal:
Re: Too early to ditch the fizz campaign

Dear Sir,

James et al report that a school-based intervention that reduced children’s consumption of carbonated drinks and the prevalence of overweight was no longer effective two years after completion of the intervention (1). We believe that this conclusion is not warranted, for two reasons.

The first reason is that the authors base their conclusions solely on the proportion of children with overweight. Indeed, this is was statistically significantly different between the intervention and the control groups at 12 months, and not at 3 years.

However, we would argue that average values of BMI, Z-score and waist circumference are better outcome values to use for a population-targeted intervention such as the CHOPPS. Geoffrey Rose pointed out that numbers of overweight or obese individuals are merely those that fall above an arbitrary cut-off point (2). The distribution of BMI in populations can be reasonably well described by a lognormal curve, of which the average shifts to higher values as the obesity ‘epidemic’ progresses (3). Similarly, for Z-scores and waist circumference population distributions can be assumed.

Table 1 makes clear that the changes in BMI, Z-score and waist circumference moved quite a bit towards significance: from p=0.36 to p=0.12, 0.60 to 0.06 and 0.81 to 0.25, respectively. Our conclusion would therefore be that the intervention did not have a significant effect on overweight after 12 months but that it is moving in the right direction.

This is not surprising. Body mass accumulates. Suppose the children learnt to consume less carbonated drinks as a result of the intervention, and that they continue to apply this knowledge as the years pass. This would result in them putting on less weight every year, which after a number of years would become visible in their body mass. We would therefore advise James and colleagues to measure the children again in another couple of years – they may well find the desired statistically significant results.

The second reason we think James et al’s conclusion is not warranted is because of trial characteristics. The trial was originally powered to detect differences in consumption of carbonated drinks, not proportion of overweight. Due to considerable loss-to-follow-up at three year power has further declined. In addition there were large differences at baseline: though not statistically significantly so, the intervention group had an average BMI, Z-score and waist circumference that was lower than that in the control group. Despite the randomisation process, we remain worried that, by chance or by selection, the intervention group might be less prone to overweight. In that case, any observed difference in the prevalence of overweight would not be (fully) attributable to the intervention.

Childhood obesity and what to do about it is a huge problem, with so far very few solutions. In our opinion, James et al dismiss what looks like a promising result, based on an inappropriate outcome measure from an insufficiently powered and poorly randomised trial.

References

(1) James J, Thomas P, Kerr D. Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS). Bmj 2007.

(2) Rose G. The Strategy of Preventive Medicine. Oxford: Oxford University Press, 1992.

(3) Veerman JL, Barendregt JJ, van Beeck EF, Seidell JC, Mackenbach JP. Stemming the obesity epidemic: a tantalizing prospect. Obesity (Silver Spring) 2007;15(9):2365-70.

Competing interests: None declared

RESEARCH:
Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality
Westaby et al. (13 October 2007) [Abstract] [Full text] [PDF]
Comparison of hospital episode statistics and central cardiac audit database in...
Public reporting of Outcomes in Surgery: Time to reflect on Bristol?
11 October 2007
Previous Rapid Response Next Rapid Response Top
Ashok I Handa,
Consultant Vascular Surgeon
Nuffield Department of Surgery, John Radcliffe Hospital, Oxford OX3 9DU

Send response to journal:
Re: Public reporting of Outcomes in Surgery: Time to reflect on Bristol?

I read with interest the report by Westaby and colleagues comparing administrative collected hospital episode statistics (HES) reported by Ayling and the clinically collected central cardiac audit database (CCAD).

This highlights the inaccuracies between HES data collected by poorly paid hospital coders working from poorly kept, and often illegible, case records and clinically collected data by dedicated data managers in the 13 cardiac centres with annual external validation.

I agree with Black (Rapid Response) that all surgical units should prospectively collect activity and outcome data. Clinicians should insist on and hospital managers should provide adequate administrative support for this to be a matter of routine. This would be good for patients as it would allow accurate public reporting of each units performance and avoid future such controversy.

On reflection on Bristol one wonders if clinically robust data such as CCAD had been available at the time, whether the GMC rulings on Dhasmana and Wisheart would have been the same. Having worked for them as an SHO in Bristol in the late 1980's, I did not doubt their commitment and dedication to their patients.

The cardiac surgical community to their credit have responded to Bristol with routine collection of clinically acquired Data for national reporting. Vascular surgeons are now also responding with the National Vascular Database organised by the Vascular Society. Unfortunately this is largely unfunded and unsupported by NHS managers.

Competing interests: None declared

FEATURE:
From small things
Reynolds (13 October 2007) [Full text] [PDF]
From small things
Chemical toxicity and mitochondria
12 October 2007
Previous Rapid Response Next Rapid Response Top
Heikki Savolainen,
Professor
Dept. of Occup. Safety & Hlth., FIN-33101 Tampere, Finland

Send response to journal:
Re: Chemical toxicity and mitochondria

Dear Editor,

This excellent feature on mitochondria contains much of the current concepts. I would like to add that the organelle, and especially its repiratory chain, is an important target of toxic compounds.

The classic examples include inhibitors of the cytochrome oxidase at the terminal of the chain. It catalyzes the formation of water and is inhibited e.g. by cyanide, hydrogen sulfide, azide or formic acid (1).

Other toxicologically important inhibitors target the succinate dehydrogenase activity at the complex II of the chain. They include e.g. malonate, 3-nitropropionic acid or alkoxyacetic acids, the end metabolites of ethylene glycol ethers (2). The latter is particularly interesting as it leads to an accumulation of succinate which interferes with the degradation of hypoxia inducible factor 1-alpha (HIF-1) which plays a role in malignant transformation (3).

Thus, mitochondrial physiology and biology are important current topics in many fields of study.

1. Savolainen H. Biological monitoring of hydrogen sulfide exposure. Biol Monit, 1991; 1: 27-33.

2. Liesivuori J, Laitinen J, Savolainen H. Rat model for renal effects of 2-alkoxyalcohols and their acetates. Arch Toxicol, 1999; 73: 229-232.

3. Brière JJ, Favier J, Benit P. Mitochondrial succinate is instrumental for HIF 1 lapha translocation in SDHA-mutant fibroblasts under normoxicconditions. Hum Mol Genet, 2005; 14: 3263-3269.

Competing interests: None declared

NEWS:
Mother asks surgeons to perform hysterectomy on daughter with cerebral palsy
Dyer (13 October 2007) [Full text]
Mother asks surgeons to perform hysterectomy on daughter with cerebral palsy
Hysterectomy/Sterilisation
12 October 2007
Previous Rapid Response Next Rapid Response Top
Vaidyanathan Gowri,
assistant professor
Sultan Qaboos University, Oman, Muscat 123

Send response to journal:
Re: Hysterectomy/Sterilisation

The "news" article on hysterectomy in a cerebral palsy child was very interesting. I have come across similar requests in my practice a few times.

The main issues are the IQ of the child to take care of herself regading menstruation and also from pregnancies (intended or unintended). Social support depends on the country they live and full time family support is not always available. It may be necessary in many circumstances to consider the maternal reqeust either for strilisation or hysterectomy and it should be based on the child's IQ and how much time the mother can devote to give attention to the child at home as well.

Competing interests: None declared

NEWS:
Tooke inquiry calls for major overhaul of specialist training
Eaton (13 October 2007) [Full text] [PDF]
Tooke inquiry calls for major overhaul of specialist training
Post-CCT "Specialist" !
13 October 2007
Previous Rapid Response Next Rapid Response Top
Stuart H McClelland,
SpR anaesthetics
Queen's Medical Centre, Nottingham, NG7 2UH

Send response to journal:
Re: Post-CCT "Specialist" !

Has no one else noticed that in recommendation 37 of the MMC report, in a diagram of the proposed structure of postgraduate training, after the award of CCT is a box titled "Specialist"? Before advancing to the "Consultant" box there is a further hurdle: "Optional higher specialist exams". Will this be the final step in our journey towards a post-CCT sub- consultant post?

Competing interests: None declared

Tooke inquiry calls for major overhaul of specialist training
Re: Tooke report
12 October 2007
Previous Rapid Response Next Rapid Response Top
D B Double,
Consultant Psychiatrist
Nofolk & Waveney Mental Health Partnership NHS Trust, Peddars Centre, Norwich NR6 5BE

Send response to journal:
Re: Re: Tooke report

Oh no, not another major overhaul of specialist training!

Competing interests: None declared

EDITORIALS:
Modernising Medical Careers laid bare
Delamothe (13 October 2007) [Full text] [PDF]
Modernising Medical Careers laid bare
ST Depression or ST Elevation?
12 October 2007
Previous Rapid Response Next Rapid Response Top
Chika Uzoigwe,
Dept Orthopaedics
Milton Keynes General Hospital,
Mark Bishay

Send response to journal:
Re: ST Depression or ST Elevation?

The Tooke report, as it exposes MTAS-gate, scrutinises a time when almost the entirety of the medical community was afflicted with ST depression or ST elevation. Despite the preliminary sound bites from the report, it must not be overlooked that there were both winners and losers. After the evolution of round 1.5, most concede that generally, excellent candidates were awarded ST posts. However, unfortunately, there remained still the "tribe" of equally excellent candidates who were not such rewarded for their distinction. The report promises transparency. This is vital and will hopefully allow the excellent and not-so-excellent losers to learn why they were overlooked as well as finding fault with the system.

There is consensus that the cream should rise to the top. However after this, there should a natural and gradual sedimentation of quality rather a polarised dichotomy of have's and have-nots; excellent and unexcellent or ST depression and ST elevation. A training programme with a single point of access would jeopardise this principle.

The report promises to make uncomfortable reading for doctors and politicians alike but this catharsis is required. Now there appears to be greater collaboration between the government and medical profession, hopefully the Tooke report will take out the depression from ST training.

Competing interests: None declared

EDITORIALS:
Screening for abdominal aortic aneurysm
Greenhalgh and Powell (13 October 2007) [Full text] [PDF]
Screening for abdominal aortic aneurysm
Screening for abdominal aortic aneurysm
13 October 2007
Previous Rapid Response Next Rapid Response Top
Hisato Takagi,
Consultant cardiovascular surgeon
Shizuoka Medical Centre, Shizuoka 411-8611, Japan,
Norikazu Kawai and Takuya Umemoto

Send response to journal:
Re: Screening for abdominal aortic aneurysm

In their Editorials, Greenhalgh and Powell(1) cited a recent Cochrane review(2) which reported that screening asymptomatic people for abdominal aortic aneurysm (AAA) significantly reduced not all-cause but AAA-related mortality in men aged 65-79 years. The review,(2) however, excluded the more recent over 15-year follow-up in the Chichester study,(3) median 9.6-year follow- up in the Viborg Country study,(4) and mean 7.1-year follow-up in the Multicentre Aneurysm Screening Study (MASS).(5) Therefore, we(6) performed a meta-analysis of currently available longest follow-up results (both AAA - related and all-cause mortality) of randomized controlled studies of screening for AAA in men.

Our comprehensive search identified four reports: the Chichester study (over 15-year follow-up),(3) the Viborg Country study (median 9.6-year follow- up), (4) the Western Australia study (median 3.6-year follow-up),(7) and the MASS (mean 7.1-year follow-up).(5) Pooled analysis of the four reports demonstrated a statistically significant reduction in both AAA-related (risk difference, |0.25%; 95% CI, |0.46% to |0.04%) and all-cause (risk difference, | 1.06%; 95% CI, |1.81% to |0.31%) mortality with screening relative to control in a random-effects model.(6)

In conclusion, our meta-analysis,(6) an update of the Cochrane review,(2) demonstrated that screening for AAA significantly reduced not merely AAA- related but also all-cause mortality in men aged †65 years.

1 Greenhalgh R, Powell J. Screening for abdominal aortic aneurysm. BMJ 2007; 335:732-3.

2 Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007;(2):CD002945.

3 Ashton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RA. Fifteen - year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007;94:696-701.

4 Lindholt JS, Juul S, Fasting H, Henneberg EW. Preliminary ten year results from a randomised single centre mass screening trial for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2006;32:608-14.

5 Kim LG, P Scott RA, Ashton HA, Thompson SG; Multicentre Aneurysm Screening Study Group. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007;146:699-706.

6 Takagi H, Tanabashi T, Kawai N, Umemoto T. Screening for abdominal aortic aneurysm reduces both aneurysm-related and all-cause mortality. J Vasc Surg (in press).

7 Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329:1259.

Competing interests: None declared

EDITORIALS:
Participation in mammography screening
Schwartz and Woloshin (13 October 2007) [Full text] [PDF]
Participation in mammography screening
False positives don´t result in overdiagnosis
13 October 2007
Previous Rapid Response Next Rapid Response Top
Christian Weymayr,
medical journalist, author of Mythos Krebsvorsorge
44623 Herne, Germany

Send response to journal:
Re: False positives don´t result in overdiagnosis

Sir, I loved to read the editorial by Schwartz and Woloshin. But one thing is not quite correct, I think: In the table one can find the sentence "Patient has at least one false positive screening examination that results in unnecessary diagnosis and treatment for breast cancer". Overdiagnosis results from in situ- cancer and invasive cancer, that means they result not from false but from true positives. This differentiation is important because even cancer experts sometimes regard false positives and overdiagnosis as the same.

Competing interests: None declared

Participation in mammography screening
And Women Over 70, over 80?
12 October 2007
Previous Rapid Response Next Rapid Response Top
Joseph More,
Retired
Retired

Send response to journal:
Re: And Women Over 70, over 80?

Is there an age beyond which one should no longer have screening mammography, or colonoscopy?

It seems that few studies are being conducted on the benefit or otherwise of screening for cancer in older people. I guess that this is due to fear of being labeled an "ageist".

It would seem that there is no benefit in very early detection of a cancer that, on average, would take a significant number of years years to become clinically manifest, in a person whose life expectancy is shorter that. But I have not been able to find any data on this question.

Competing interests: None declared

EDITOR'S CHOICE:
The way of the world
Delamothe (13 October 2007) [Full text]
The way of the world
What doctors should tell their patients about CAM
12 October 2007
Previous Rapid Response Next Rapid Response Top
Roger A Fisken,
Consultant physician
Friarage Hospital, Northallerton, DL6 1JG

Send response to journal:
Re: What doctors should tell their patients about CAM

You are quite right to highlight the problem of excessive tolerance of CAM and your comments are particularly timely in the light of Prof Ernst's recent publication and the criticisms of CAM from the U.S.A. Is it not now time for the BMJ to commission a themed issue entitled "Why doctors should warn their patients to be sceptical of CAM"? Perhaps Prof Ernst might be invited to be guest editor.

Competing interests: None declared

RESEARCH:
Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review
Pewsner et al. (6 October 2007) [Abstract] [Full text] [PDF]
Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in...
Left ventricular hypertrophy and QT dispersion in hypertensive patients
11 October 2007
Previous Rapid Response Next Rapid Response Top
Antoni Sisó Almirall,
Associate Professor of Medicine. University of Barcelona
Les Corts and Gòtic Primary Care Centers. Barcelona. Spain,
Antoni Dalfó Baqué.

Send response to journal:
Re: Left ventricular hypertrophy and QT dispersion in hypertensive patients

Electrocardiography (ECG) is the usual method for identifying left ventricular hypertrophy (LVH) on standard hypertensive evaluation in primary care. Usually, diagnostic criteria for LVH by 12-lead ECG use a recognized criteria such as Sokolow-Lyon, Casale/Devereux, Cornell product, Cornell voltage, or a combination of variables such as QRS voltages, QRS duration and time-voltage QRS area (1). QT dispersion (QTd), as a measure of interlead variations of QT interval duration in the ECG, may serve as a measure of variability in ventricular recovery time. QT dispersion (QTd) is a recognised predictor of sudden death in patients with hypertrophic cardiomyopathy and congestive heart failure (2). The incidence of sudden death is also increased in hypertensive population with LVH (3).

We investigated the relationship between increased left ventricular mass index (LVMI) in hypertensive patients and QT dispersion of standard electrocardiograms, and calculated the sensitivity and specificity of a QTd value for determine LVH. We analized 125 patients (41 males and 84 females) with essential hypertension. Patients with bundle branch block, coronary heart disease or patients that had receiving an antiarrhythmic drugs were excluded from the study. Standard 12-leaded electrocardiograms were measured in sinus rhythm in all 12 leads by a single blinded observer. QT intervals measurements were obtained from a image-digitalized system (Snap-Scan AGFA). QT interval was taken from the beginning of QRS complex to the end of the T wave (return to isoelectric baseline). If U wave was present, QT interval was measured to the nadir of the curve between T and U waves. QTd was defined as the difference between the maximum (QTmax) and the minimum QT interval. A rate-corrected QT dispersion (QTdc) was calculated by Bazett's formula. Echocardiografic examination was evaluated in all patients according to the recommendation of the American Society of Echocardiography. M-mode echocardiographic left ventricular mass was analysed: criterion of LVH was LVMI above 134 gm/m2 in men and above 110 gm/m2 in women (4). Results are expressed as mean (SD) and statistical analysis was done by using the SPSS software package. Linear regression analysis was performed between all measured variables. QTd accurancy was analized using receiver operating characteristic (ROC) curves analysis.

There were 78 patients (62.4%) with LVH. The mean age were 64.3 (9.6 years), range 29 to 82. The Pearson’s correlation coefficient (r) between QTd and LVMI, QTdc and LVMI and QTmax and LVMI were 0.54 (p < 0.0001), 0.50 (p < 0.0001) and 0.34 (p < 0.0001), respectively. Test performance of QTd for identification of LVH was better in women than in men, with higher areas under the ROC curves in women (0.82 in women and 0.80 in men). In men, a QTd of 48.0 miliseconds provided a sensitivity of 89.5% (66.9-98.7) and specificity of 59.1% (36.4-79.3); otherwise, in women a QTd of 43.6 miliseconds provided a sensitivity of 83.05% (71-91.6) and a specificity of 64% (42.5-82).

These findings suggest that QTd is a useful noninvasive parameter for LVH detection in hypertensive patients, and may play an important role for improve identification of LVH by 12- lead ECG compared with other electrocardiographic criterias.

References.

1. Okin PM, Roman MJ, Devereux RB, Pickering TG, Borer JS, Kligfield P. Time-voltage QRS Area of the 12-lead electrocardiogram. Detection of left ventricular hypertrophy. Hypertension 1998;31:937-942.

2. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. The Lancet 1994; 343:327-9.

3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med 1991; 114:345-52.

4. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of a method. Circulation 1977; 55:613-18.

Competing interests: None declared

ANALYSIS:
Adding fluoride to water supplies
Cheng et al. (6 October 2007) [Full text] [PDF]
Adding fluoride to water supplies
Fluoridation and aluminium
13 October 2007
Previous Rapid Response Next Rapid Response Top
Christopher Exley,
Reader
Keele University ST5 5BG

Send response to journal:
Re: Fluoridation and aluminium

I was surprised that no mention was made of the role that fluoride plays in increasing human exposure to aluminium via gastrointestinal absorption? Aluminium binds fluoride with great avidity and fluoride in drinking water will both facilitate the gastrointestinal absorption of aluminium which is coincidentally present in drinking water but more importantly it will increase the absorption of aluminium from ingested foodstuffs and other beverages. Fluoridation of the potable water supply will lead to higher human body burdens of aluminium. Whether a higher body burden of aluminium should be avoided is, of course, another debate.

Competing interests: None declared

Adding fluoride to water supplies
A question of the common good
12 October 2007
Previous Rapid Response Next Rapid Response Top
C Albert Yeung,
Consultant in Dental Public Health
Lanarkshire NHS Board, Hamilton ML3 0TA

Send response to journal:
Re: A question of the common good

Cheng et al questioned the ethical issue of water fluoridation surrounding informed consent and human rights. [1] However, there is another side of the coin.

Clearly there is scope for different points of view on the ethics of any major issue of public policy, including water fluoridation. Anyone who takes up the position that the individual has the right to decide the precise composition of water supply is unlikely to accept water fluoridation as anything less than an intrusion. Does that mean he or she can prevent the chlorination of water simply because of a personal aversion to chlorine? [2]

Drinking fluoride-free water is not a basic human right but a question of individual preference. In a society where people come together for mutual benefit, it is a question of balancing such personal preferences against the common good arising from the lower levels of tooth decay which water fluoridation brings.

Individuals cannot make decisions about the composition of the public water supply. These decisions must be made at the community level. The minority who have an ideological objection to water fluoridation do not have a right to impose excess risk on the majority, just because of their personal preference. It could be argued that where there is majority community support, it is unethical not to fluoridate water supply.

1 Cheng KK, Chalmers I, Sheldon TA. Adding fluoride to water supplies. BMJ 2007; 335: 699-702. (6 October.)

2 British Fluoridation Society. One in a Million – the facts about water fluoridation. Manchester: British Fluoridation Society, 2004.

Competing interests: None declared

OBSERVATIONS:
An age old problem
Richards (6 October 2007) [Full text] [PDF]
An age old problem
Self Management :An age old solution to an age old problem
13 October 2007
Previous Rapid Response Next Rapid Response Top
Arun K Chopra,
Special Lecturer,Nottingham University
QMC,Derby Road,Nottingham,NG7 2UH

Send response to journal:
Re: Self Management :An age old solution to an age old problem

Dear editor,

There is no doubt that the demographic changes which we are currently living through will have a major impact on health and social policy in the years to come. An increasingly older population will be more likely to suffer from one or more chronic diseases. Coupled with this, is the rise of depression which is projected to be the largest cause of morbidity by 2020 and which has recently been shown to cause the greatest decrement in health as compared to other chronic diseases, asthma, angina,arthritis and diabetes. The combination of depression with any of these illnesses leads to a greater health decrement than any other combination amongst these illnesses (Moussavi et al,2007). One possible solution to this increasingly complicated scenario is strenghtening the position of self management of chronic illness through models of healthcare delivery such as the collaborative care model. (www.improvingchroniccare.org-accessed 11/10/07)This model has demonstrated effectiveness in both physical and mental ill-health, although its application outside of research trials remains limited. More recently, concerns have been expressed over the value of self monitoring in Diabetes, with researchers reporting no significant gains from such practice(Farmer et al, 2007). In order to bring this possible solution to bear, professionals need to be supportive of patients who collaboratively self manage, there needs to an improved response to problems identified through self management and research is needed to elucidate the patient pathways to self management in order to ensure that the appropriate self management package is provided to a patient at the right stage of their illness course and tailored to the degree of psychological readiness they have to tackle the challenges of living with a chronic illness.

References

Farmer,A. et al (2007)Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.BMJ ;335: 132 Moussavi,S. et al (2007)Depression, chronic diseases, and decrements in health: results from the World Health Surveys.The Lancet;370:851-858

Competing interests: None declared

An age old problem
Right to die?
12 October 2007
Previous Rapid Response Next Rapid Response Top
Peter Bruggen,
retired psychiatrist
21 Mackeson Road NW3 2LU

Send response to journal:
Re: Right to die?

Yes, as far as you go, but I am sorry that you duck consideration of a right to die.

I am pleased at your concern for dignity and rights of the elderly, but what if our wishes are to die? We talk of rights to freedom to health care, to justice, to being treated with respect and not abused. But, what if, at the end I simply want to die?

I do not mean if I am suffering from a treatable depressive disorder. Treat that and I might try again.

I mean if, at the end, with ‘all said and done’, all treatments tried, I am still in more pain, more discomfort, or with more memory loss than I want or want those caring for me to endure; and if I am not able physically to kill myself (no illegality there). Then what about helping me? I know it is not legal in this country, but it is in some. Is not denying me that help an ‘indignity’, a ‘neglect’ or indeed even a ‘cruelty’.

It does sound as if a supported suicide bill or a euthanasia bill would have public support. It does sound as if the feared-for abuses have not occurred in Oregon, Holland or Switzerland. At least let’s talk about it.

Peter Bruggen
Retired psychiatrist

Competing interests: None declared

FEATURE:
Should general practitioners resume 24 hour responsibility for their patients? Yes
Jones (6 October 2007) [Full text] [PDF]
Should general practitioners resume 24 hour responsibility for their patients? Yes
Not either or...
13 October 2007
Previous Rapid Response Next Rapid Response Top
Steven Ford,
GP
Haydon & Allen Valleys Medical Practice

Send response to journal:
Re: Not either or...

Editor

There need be no contest here, merely the flexibility to adopt the approach that best suits the patients, doctors and geography.

My own practice did its own OOH until confronted by 'force majeur' and I only stopped doing OOH altogether when it degenerated into a call centre operation.

A diversity of provision arrangements is the right approach.

Yours sincerely

Steve Ford

Competing interests: I am a GP

Should general practitioners resume 24 hour responsibility for their patients? Yes
GP Land
13 October 2007
Previous Rapid Response Next Rapid Response Top
Dr. Raja Baber Sheraz,
GP ST2
Staff hostel, West cumberland hospital, Whitehaven, CA28 8JG.

Send response to journal:
Re: GP Land

Gp treats the whole patient, not "chest pain", "ankle fracture" or "another neck of femur". Thats what we call as "Holistic approach" in our GP land. Even if the GP works from 0800 to 1700 it does not mean that he/she is not owning the patient. GP gets the feedback from the patient very next day that is not the case in minimum three monthly hospital consultation. At the moment the balance is right between the primary & secondary care. Yes i do support the transition of some specialist work into community, closer to patients own home provided by their own doctor. GPWSI Cardiology is an example! To maintain & improve the quality of general practice we need to give our GP`s a suitable work life balance by giving them the choices of opting in or out of out of hours work. General practice has become a emerging popular choice among our post foundation programme doctors. Bringing out of hour work into primary care "24 hours responsibility" may affect the future career choices! In the current setting General practitioners are doing a great job in providing excellent healthcare to the local community. Suggestion: Why not make small primary care zones & GP`s can do out of hour work in their own practice zones. The benefit would be that patient requiring home visit won`t see a new face! I am sure with this healthy debate we might find an acceptable solution to all which continues to provide the best primary care to our local communities. The important bit would be to include hospital Consultants, GP`s, Current out of hour providers, media & most importantly our own patients!

Competing interests: None declared

Should general practitioners resume 24 hour responsibility for their patients? Yes
In support of the GP Co-op
12 October 2007
Previous Rapid Response Next Rapid Response Top
john m caine,
GP
parbold, lancs, wn8 7nb

Send response to journal:
Re: In support of the GP Co-op

Prof. Roger's arguments for the return of 24 hr 7/7 responsibility seem to be that it would improve GP training, reduce admissions and improve patient use of the service and their safety. Oh and that patients would like it and it might be cost effective.

His evidence for these assertions is what exactly?. He states that Heath's (1) opinion was that 'OOH was becoming a shambles' -yet her article is actually calling for an end of the cheaper skill-mixing attempts of some OOH services to introduce non-GP first contact clinicians into OOH and promots the GP Co-ops who have managed to stay in business by opting -in.

He claims that Wanless (2) blamed the steep rise in A&E; attendances to changes in OOH arrangements - but Wanless actually blames the A&E; obsession with 4 hr waiting times along with the OOH changes and gives no evidence for either - In fact the steepest year on year rise in new contacts occurred between 2002/3 and 2003/4 (15% increase) before the new contract came into effect c/w 9% between 2003/4 and 2004/5, and 6% and 2% in the last 2 years.

He claims that OOH is provided by 'less experienced clinicians'. Where is his evidence for this assumption?. Does he have a breakdown of the OOH workforce, that no one else has, or is he still peddling the media prejudice?

My prejudice is that the vast majority of complaints in the MPS report he quoted will be in those organisations whose main aim is to provide a service based on cost rather than quality, i.e. the private companies and the in- house PCT run organisations- by the way how does the rise in OOH complaints compare with the number of complaints about the NHS in general? Is there a general increase in complaints across the NHS or just in those who are getting the worst press?

It is difficult to see what points he is trying to make from his international comparisons. Australia have a private health care system where GPs get paid for each contact and where GPs can reckon on only a third of their registered patients seeing them regularly -the others popping into whichever GP takes their fancy. Roger espouses their stringent guidelines for communication but doesn't elaborate on these. My personal experience of working OOH and in hours in Australia is that continuity of care is a shambles. The OOH quality standards in this country (3) insist on all OOH contact records being faxed/ emailed to the patient's GP by 8am the next morning- If only information regarding our patients’ attendance at A&E; or Walk-in centres came as quickly ( I’ll leave to one side the scandalous time it takes to get outpatient letters or discharge summaries)

In Canada they apparently have a system of extended rotas, which he claims is what Heath also calls for. This sounds fine to me but we haven’t we been there already? Oh yes I remember they are called GP co-ops!

Where these have been allowed to carry on- either by opting in and doing their own thing a la Heath, or by opting out yet being unmolested by PCTs- they continue to provide a high quality service, staffed by local experienced GPs, with excellent lines of communication, and support for younger doctors and training for registrars- does that tick all your boxes?

1.Heath I. Out of hour’s primary care—a shambles? BMJ 2007; 334:341. 2.Wanless D, Appleby J, Morrison A, Patel D. Our future health secured? A review of NHS funding and performance. London: King's Fund, 2007. 3. national quality requirements in the delivery of Out of Hours services: 2006

Competing interests: full time GP and OOH Director

Should general practitioners resume 24 hour responsibility for their patients? Yes
24hour responsibility
11 October 2007
Previous Rapid Response Next Rapid Response Top
ravinder Norman,
GP
YATELEY GU46 7LS

Send response to journal:
Re: 24hour responsibility

NO to OOH-our daily practice demonstrates that the more availability we have the greater uptake .NHS Direct A&E; walk in clinics do not necessarily prove that there is a need.[A vacuum is filled]Other than true emergencies -of which there are few-most of health care needs can be dealt with during normal working hours. A trial of GP's in A&E; only demonstrates how perceived needs by the public and desire to be seen when, where etc, fuelled by the Governments desire to give everyone what they want rather than sensible use of services -this is not rationing-creates a need where there wasn't any.

The best way as was just beginning to be shown by fund holding then by local GP co-ops is that given funding and support and the trust by MPs .GP's can deliver very good, comprehensive services.

Competing interests: None declared

Should general practitioners resume 24 hour responsibility for their patients? Yes
depends on format
11 October 2007
Previous Rapid Response Next Rapid Response Top
Duran Kandhai,
GP-Principal
Newport, NP19 8XR

Send response to journal:
Re: depends on format

GPs are independent contractors and I feel that any action even by stealth to impose working unsociable hours(out of hours; 24/7 care) is certainly not acceptable and should forcefully with full support by all stakeholders be rejected. Nonetheless I agree that many GPs would be willing to work OOH(Out Of Hours; 24/7 care)and indeed should have the opportunity to do so in a suitably priced contract, i.e. that reflects the risks, time investment and sacrifice of family/social life. Furthermore some arrangement should be possible whereby the GP who worked the evening or night before should have at least the next morning off. This would be the only way forward to achieve 24/7 care that is acceptable to both patients and doctors. Let's not forget that patients nowadays regard a tired and overworked doctor as "non acceptable" or "risky".

Competing interests: I'm a GP Principal

Should general practitioners resume 24 hour responsibility for their patients? Yes
24 hours
11 October 2007
Previous Rapid Response Next Rapid Response Top
Gregory M Read,
GP
Fressingfeld Medical Centre IP21 5PJ

Send response to journal:
Re: 24 hours

I would love to go back to the good old days of 24hr responsibility (it was actually one of the reasons I chose general practice as a career), if there was the necessary support for carrying it out, in both financial terms and in generating an attitude from the patients that it was not an extension of our daytime work - an attitude persistently encouraged by the present Government with its obsession with access. Unfortunately, neither of these pre-requisites will happen.

The Government has blatantly encouraged patients to expect a service at weekends and out of hours that is unacceptable to most hardworking general practitioners - this attitude is based on the Tesco's model of "get what you want when you want it" even if it is 3 o'clock in the morning. The difference is that Tesco's know that they can afford to do it making a fabulous profit to boot and also employ their staff on a shift- based system. The person on the cash till at 3 o'clock in the early hours won't be there holding the fort at 9 o'clock later the same morning! The deliveries arrive and the shelves are stocked to accomplish a seamless shopping experience even though it is at a time when most people are asleep. I doubt whether hospitals and other areas of the NHS will be able to provide an equivalent routine service during these times to make our efforts worthwhile when we are providing the required routine OOH service that will be expected of us. If one looks at the way most PCT's organise their finances in order to pay off the massive debts that were there when they came into being, they exert a huge downward pressure on practices to do everything as cheaply as possible or stop commissioning certain services because they are too expensive. How on earth are they going to afford a 24hr service manned by doctors when they are finding it so difficult to provide one on the cheap at present with nurse practitioners and paramedics and bases spread so thin that our patients sometimes have to travel 50 miles to see a doctor or other healthcare practitioner. I worked out that when I did my OOH work and Saturday mornings for the first 10 years in practice, I earned about a pound an hour! I also missed my young daughter growing up in her early years because of the times that I wasn't there. This is something that I would not accept again, especially as I am much older and I wouldn't expect my younger colleagues to be put in the same position. Even when we set up an innovative General Practice Co-operative in our area, it was apparent, as time went by, that the service was starting to be abused by an increasing number of unnecessary calls and the added stress that came with them. And of course to provide this service we had to pay back our membership by working the requisite number of shifts.

Professor Jones, I'm afraid, is typical of the type of GP, who, despite of his excellent skills as a GP, has found other things to do in the world of academia - and this is not denigrating that what he does isn't important for British General Practice. If I am wrong then I apologise, but I doubt whether he spends every week of his working life from 8-6.30, on the coalface, seeing patients and, thus, in his own way, he has already opted out.

I hope that I am not a dinosaur and that there maybe many GPs who feel the same as me. If it comes to the crunch then I will consider my options and retire early, even though it will affect my financial future. I don't think anyone would disagree with the fact that a doctor based OOH system and thus, a return to 24hr responsibility would be the gold standard for general practice OOH but, it requires a sea change in attitude, particularly from this and future Governments - they cannot rely on doctors goodwill to work unsociable hours for no additional income because it's perceived to be a duty that comes with the job. I think that this was why so many of us decided that enough was enough in 2004 and opted out. The only way that a return to 24hr responsibility will work, is if the number of GPs working in the NHS increases dramatically in order to allow a practice-based shift system to work effectively and safely, as well as there being a secure and protected financial package for those who carry it out.

Competing interests: None declared

Should general practitioners resume 24 hour responsibility for their patients? Yes
Not keen!
11 October 2007
Previous Rapid Response Next Rapid Response Top
Rosemary B Martin,
GP principal
M14 6 XU

Send response to journal:
Re: Not keen!

The day job has undoubtedly got harder under the new contract. The patients who consult by day have every bit as much right to a good service and the two jobs cannot safely be done by the same person.

Competing interests: None declared

FEATURE:
Industry funded patient information and the slippery slope to New Zealand
Toop and Mangin (6 October 2007) [Full text] [PDF]
Industry funded patient information and the slippery slope to New Zealand
Anecdotal instance of positive effects of drug advertising
13 October 2007
Previous Rapid Response Next Rapid Response Top
Charles L. Rogerson,
Clinical Data Architect
slough sl1 1th

Send response to journal:
Re: Anecdotal instance of positive effects of drug advertising

I think this article doesn't give enough weight to the intelligence of patients and their interest in getting information about their medications.

Anecdotally, an older acquaintance of mine in the States who was a very active hiker developed fairly rapid onset of bilateral leg weakness which increased over a year to the point where he could only walk very short distances. He consulted his GP and several specialists and was finally referred for spine surgery, which he declined.

He then saw an ad for a statin he was taking on television, in which the narrator at the end listed the side-effects, which included muscle weakness. He immediately went to his GP, who DC'd the statin.

The leg weakness immediately improved, though unfortunately not completely. Somehow his physicians had missed this rather obvious possibility.

I believe this may demonstrate that in a clinical environment where clinicians do not communicate fully to their patients the mechanisms and side-effects of prescribed medications, televised medication advertisements similar to those published in medical publications can play a positive role in educating patients.

Competing interests: None declared

NEWS:
UK does well on giving information to patients but poorly on access to new treatments
Watson (6 October 2007) [Full text] [PDF]
UK does well on giving information to patients but poorly on access to new treatments
Bismark v. Beveridge
11 October 2007
Previous Rapid Response Next Rapid Response Top
Iain S Fraser,
GP
Manchester, M12 5LH

Send response to journal:
Re: Bismark v. Beveridge

The Euro Health Consumer Index, 2007 is being cited as evidence that the Bismark system 'delivers better value' than the Beveridge system. One might however pause to consider some other health statistics from the WHO:

Per capita total expenditure (US$) Germany 3521.4 UK 2899.7
Hospital beds per 100000           Germany 844.49 UK 389.79
Physicians per 100000              Germany 340.20 UK 389.79

Surely it is premature to draw conclusions on the merits of one system over another when the playing field is far from level.

Competing interests: None declared

NEWS:
Africans die in pain because of fears of opiate addiction
Logie and Leng (6 October 2007) [Full text] [PDF]
Africans die in pain because of fears of opiate addiction
Opiates for pain in dying patients and in those with sickle cell disease
11 October 2007
Previous Rapid Response Next Rapid Response Top
Felix ID Konotey-Ahulu,
Kwegyir Aggrey Distinguished Professor of Human Genetics, University of Cape Coast, Ghana
Consultant Physician Genetic Counsellor, Ten Harley Street, London W1N 1AA

Send response to journal:
Re: Opiates for pain in dying patients and in those with sickle cell disease

Opiates for pain in dying patients and in those with sickle cell disease

Dorothy Logie and Mhoira Leng’s report of 6 October describes a conference in Nairobi which highlighted opiophobia – the fear of using morphine therapeutically – “as a big obstacle facing palliative care services in the (African) continent” [1]. The conference was concerned with dying patients. In his rapid response, however, Jecko Thachil concentrated on the use of opiates in sickle cell disease patients. He states that while “very high amounts of opiates (often in hundreds of milligrams) are often required for the patients who suffer from recurrent sickle crises” [2], the expected analgesic effect leaves much to be desired, not to mention side-effects. Dealing with terminally ill patients is one thing; opiate administration to sickle cell disease patients is something else entirely.

Dr Thachil feels an “increased need for additional education regarding sickle cell disease…” Has he examined the experiences of two physicians who personally supervised thousands of people with sickle cell disease on both sides of the Atlantic continuously for years? [3, 4] Treating sickle cell disease is not the same as managing the sickle cell disease patient [5]; the difference in the two approaches tending to separate haematologists on the one hand, from physicians and family practitioners on the other. When a white British consultant physician in a London teaching hospital complained that “the haematologists here have created a cohort of addicts” [6] a white consultant haematologist in another London teaching hospital tore strips off him, accusing him of being a racist for depriving suffering black patients of pain relief, an attack which made me respond thus: “White physicians who, at the risk of being misunderstood by (that haematologist), voice their displeasure at what they see happening on their wards deserve commendation, not condemnation” [7].

Not far from where Dr Jacko Thachil works, also on Merseyside, “during a ward round in a provincial teaching hospital with consultant haematologists on March 6, 1997, I was shown a woman who had been on continuous opiate infusion since September, 1996” [7]. I went on to say in my Lancet communication: “Far from the consultants taking umbrage because I pointed out that the patient could not have been in sickle cell crisis for 6 months, they were happy to discuss with me the way forward” [7]. Dr Thachil feels “an increased need for additional education regarding …addiction to pain medication…and treatment of pain” and he concludes “but who and where these should be focussed on is a matter for debate” [2].

Not a matter for debate at all in my opinion: May I suggest to him certain facts he might wish to probe in his quest for education?

(a) “In Jamaican experience ..morphia or its derivatives are rarely used or necessary” [8] How did Graham Serjeant achieve this?

(b) “Most painful crises may be treated in a day-care centre, the patient returning home in the evening” [9] How is this possible if hooked up on morphine or diamorphine pump “as in the recommended UK protocol”? [6]

(c) “We are convinced that the chest syndrome in the UK and the USA is not entirely unrelated to the routine use of opiates in those countries for sickle cell crises”. [10] Some nurses I am in touch with can write an MSc thesis on this.

(d) Goodman from the USA (where diamorphine is banned for patients) found the use of ketorolac in painful sickle cell crises as efficient as morphine but without the latter’s respiratory depression [11]. So why do British haematologists prefer to use morphine and diamorphine? Answer: “Ketorolac has no product licence in the UK for this indication” [12]

(e) Two questions that I have asked British Haematologists several times but which have never been answered, and which Dr Thachil may now ask the National Institute of Clinical Excellence (NICE) for help in answering:

(i) “Why do West African and West Indian patients with sickle cell disease who did without morphine in their countries have to be given morphine pumps during sickle cell crises when they come to the United Kingdom?” [6, 13]

(ii) If pain from whatever cause deserved the most potent analgesic, and dysmenorrhoea has been known to be intolerably painful, would a British haematologist “not consider it unwise for a hospital to administer diamorphine as routine management of young women?” [7]

Four encouraging signs have emerged in the UK since I have been voicing my displeasure at the use of diamorphine and morphine pumps for patients with sickle cell crises: (1) Some haematologists in the UK and the European continent have abandoned the practice in spite of what the ‘approved protocol’ displays in the emergency rooms. (2) Some sickle cell disease patients have become more vocal in their displeasure of the practice. To them ‘opiophobia’ is not to be condemned [1], but commended. (3) Some family practitioners are looking after their patients at home, using intravenous fluids and other than powerfully addictive opiates to help these patients instead of submitting them to hospital care. (4) A clearer grasp of the causes of crisis has put more emphasis on public health measures (fluids, warmth, treatment of infections, dressing properly, anticipating hazards, immunisations, avoiding tobacco and alcohol), enabling patients prevent crises and helping them use the excellent non-sickling genes they have inherited from their parents to achieve as much of their full potential intellectually as possible [10].

It is therefore not surprising to find that the sickle cell disease patients who have become lawyers, teachers, businessmen and women, nurses & midwives, pharmacists, and even doctors are those whose haematologists have abandoned the opiate culture. Occasionally, however, one found even professors of haematology who would defend the prescribing of diamorphine for a sickle cell disease patient with severe difficulty in breathing. “Chest syndrome” was always there to blame, if the patient died [6].

When in my genetic counselling and family size limitation (GCFSL) drive in Ghana and in the Ghanaian community here in the UK I sense that the urgency of my message is being glossed over I tell my fellow countrymen and women in plain language that if they continue to procreate at the rate they are doing, and more sickle cell disease (ACHE/ACHE) patients are born, the chances are that in the UK they may end up on a heroin drip. This concentrates the mind, and they listen to me. “One in three of you is a NORM/ACHE. Do you want to end up with ACHE/ACHE children who will be given heroin for pain?” [http://www.konotey- ahulu.com/diagram.asp]

Felix I D Konotey-Ahulu MD(Lond) DSc (UCC) FRCP DTMH FGA FGCPS FAAS FTWAS
Kwegyir Aggrey Distinguished Professor of Human Genetics, University of Cape Coast, Ghana and Consultant Physician Genetic Counsellor, Ten Harley Street, London W1N 1AA, England.

Conflict of interest: None declared

1 Logie D, Leng M. Africans die in pain because of fears of opiate addiction. BMJ 2007; 335: 685

2 Thachil J. The fear of opiate addiction – not unique to Africa. Rapid response BMJ 2007, 8 October.

3 Serjeant GR. Sickle cell disease. Oxford: Oxford university Press, 1992 (Second Edition)

4 Konotey-Ahulu FID. The sickle cell disease patient. London: Macmillan 1991; Waftord: Tetteh-A’Domeno Co, 1996.

5 Konotey-Ahulu FID. Sickle cell disease and the patient. Lancet 2005; 365: 382-383.

6 Konotey-Ahulu FID. Opiates for sickle cell crisis? Lancet 1998; 351: 1438.

7 Konotey-Ahulu FID. Opiates for sickle cell crisis. Lancet 1998; 352: 651-652.

8 Serjeant GR. Sickle cell disease. Oxford. Oxford University Press, 1985, page 204.

9 Serjeant GR. Sickle cell disease. Lancet 1997; 350: 725-730.

10 Ringelhann B, Konotey-Ahulu FID. Hemoglobinopathies and thalassaemias in Mediterranean areas and West Africa: historical and other perspectives 1910 to 1997. Atti dell’Accademia delle Scienze di Ferrara 1998; 74: 267-307.

11 Goodman E. Use of ketorolac in sickle cell disease and vaso- occlusive crisis. Lancet 1991; 338: 641-642.

12 Liesner RJ, Vandenberghe EA, Davies SC. Analgesics in sickle cell disease. Lancet 1993; 341: 188.

13 Konotey-Ahulu FID. Morphine for painful crises in sickle cell disease. BMJ 1991; 302: 1604.

Competing interests: None declared

LETTERS:
A cheap soundbite
Magos et al. (6 October 2007) [Full text] [PDF]
A cheap soundbite
Cold hands warm heart
12 October 2007
Previous Rapid Response Next Rapid Response Top
Karen J Hebert,
F2 Doctor
UBHT, Bristol, BS65SW

Send response to journal:
Re: Cold hands warm heart

I have been following the 'bare below the elbows' debate with interest. White coats have been a thing of the past since I was a student and we are now informed that we should not be wearing watches on the wards. Indeed one of my university friends who works at a different trust has to go through special "decontamination procedures" because she works on the C-Difficile bay in her hospital.

The issue I would like to raise may seem a minor one to doctors but is one of reasonable significance to the patients we examine. I have very cold hands - something which is only moderately alleviated by ensuring I dress warmly. I nonetheless still find that my hands are cold enough to make patients remark. Of course I always warn them in advance - to which most of them respond ,"Don't worry dear...cold hands warm heart!"

This is not something that is unique to me...and I believe with the new dress policies that seem to be coming we will either need to bump up the heating (good breeding ground for bacteria?) or have an awful lot of patients suffering!

Perhaps we will be offered hypoallogenic, antimicrobial mittens as a solution...

Competing interests: None declared

EDITORIALS:
Reform of the coroner system and death certification
Luce (6 October 2007) [Full text] [PDF]
Reform of the coroner system and death certification
Unintended consequences
12 October 2007
Previous Rapid Response Next Rapid Response Top
Laurie R Davis,
GP
South Hermitage Surgery , South Hermitage, Shrewsbury sy3 7js

Send response to journal:
Re: Unintended consequences

Dear Sir ,

One aspect of the changes described by Luce might be the loss of incentive for involvement by the removal of payment to the doctors involved in signing the cremation form.Payment for such a service is ethically questionable ,but currently creates an incentive for GPs to engage in the process.If this is removed ,I predict a loss of interest in this traditional role.Our current terms of service imply that our Duty of Care ceases with the death of the patient.Fitting in a trip to the undertaker or the medical examiner service becomes another unpaid chore and I suspect will tempt doctors to refer more deaths to the coroner on the uncontestable grounds of medical uncertainty, especially if we move further into a culture of blame.Presumably this will result in more postmortems.Or is this the intended consequence?

Yours Sincerely,

Laurie Davis

Competing interests: Future recipient of death certification. Current recipient of occasional cremation fees.

EDITORIALS:
Encouraging children and adolescents to be more active
Giles-Corti and Salmon (6 October 2007) [Full text] [PDF]
Encouraging children and adolescents to be more active
Working harder together to tackle obesity
12 October 2007
Previous Rapid Response Next Rapid Response Top
Shalini Pooransingh,
Locum Consultant in Public Health Medicine
Walsall Teaching PCT, Jubilee House, Bloxwich Lane, Walsall WS2 7JL

Send response to journal:
Re: Working harder together to tackle obesity

Editors,

We agree with Giles- Corti and Salmon(1) about a multi component interventions approach to tackling exercise levels in children and adolescents, particularly its emphasis on involving parents and families.

In fact this is the basis of health promotion strategies (2)which recognize the need for healthy public policy, supportive environments, strong community action, personal skill development and a reorienting of health services which may all be necessary to effect change.

Our interest in this editorial stems from the fact that in Walsall we engaged in measuring children on a pilot basis in 2006 (3) before Department of Health (DoH) stipulated that these measurements ought to be done routinely. 1904 children were measured in reception year and years 6, 7 and 10. This equated to 11% of all school children in those years. There were 6% opt outs and those who were absent or withdrew were from higher years and were found to be obese from previous measurements.

We would like to share the findings from this pilot. Six out of eight schools returned evaluation forms and five of these (83%) reported that they clearly understood the aims of the project.

Forty-eight younger children (26% response rate) returned evaluation questionnaires and of these, 58% didn’t know how they felt about being measured and 30% didn’t know why they were being measured.

Many of the year 7s and 10s said they would have liked more information about the measurement process. Although DoH doesn’t recommend sharing results several children wanted to know their measurements and we support this because how can you engage people to take responsibility for their health without providing full information.

Feedback recommended that there should be a coherent approach to tackling obesity across all agencies as it appears that the link between the healthy schools initiative and the measurement process was not being made by some participants.

We therefore need to work harder together because despite all initiatives over the years it appears that children still don’t understand why they were being measured. We have identified another key group of persons – parents as they are the ones who make decisions about foods available in the household and give permission and money for sporting and exercise related activities. Indeed Blair et al (4) report that maternal factors including maternal activity and television watching are associated with percentage body fat in children at 7 years of age.

Dr Sam Ramaiah
Director of Public Health

Dr Shalini Pooransingh
Locum Consultant in Public Health Medicine

Walsall teaching PCT

References

(1)Giles- Corti B, Salmon J Encouraging children and adolescents to be more active Well evaluated complex interventions are still neededEditorial BMJ 2007; 335:677-8.

(2)Donaldson LJ Donaldson PJ Essential Public Health Medicine Libra Pharm Limited 2000.

(3)Evaluation of a Pilot Study to Monitor Childhood Obesity in Walsall Walsall tPCT August 2006.

(4) Blair N, Thompson J, Black P et al Risk factors for obesity in 7 – year – old European children: the Auckland Birthweight Collaborative Study Arch Dis Child 2007; 92:866-871.

Competing interests: None declared

VIEWS & REVIEWS:
MTAS or a tale of evidence heedless medicine
Nachev (22 September 2007) [Full text] [PDF]
MTAS or a tale of evidence heedless medicine
Selection methodology: more fiction than fact, and a worrying future
12 October 2007
Previous Rapid Response Next Rapid Response Top
A Thomson,
Doctor
London

Send response to journal:
Re: Selection methodology: more fiction than fact, and a worrying future

Although Prof Patterson claims that "there is over a century’s literature on selection methodologies," it is disappointing that 7 out of 8 of her references are self-citations.

Prof Patterson fails to address the question "why change?" other than stating that the reasons for change rested on the potentially flawed belief that doctors should be forced to choose a speciality with no prior relevant experience. She neither questions nor attempts to justify the validity of such a significant assumption - how can she then justify any process which is based on it?

Her account of the development process, if true, is very worrying - although she attempts to distance herself from the disaster, she does admit her involvement, with the admission that selection forms for entry above ST1 were hastily cobbled together "from existing application forms", that there is no evidence of their validity outside of GP selection.

Prof Patterson was aware of the flaws, and could have used her authority as an expert in selection methodology to halt this sorry process which wasted so much time. She could have objected, refused to allow her work to be implemented in this way and firmly recommended continuing with current selection procedures. Why did she do none of these things? Why did she press ahead with an enormous human experiment for which no ethical approval had been sought or granted, and to which the subjects had not consented. Her reply addresses none of these questions, and I find it rather sinister that she is already looking to the future without attempting to learn from the terrible mistakes in her recent past.

Competing interests: Dr Thomson was one of the thousands of UK doctors who were sacked and made to reapply for their own jobs using flawed selection methods which Prof Patterson and the Work Psychology Partnership helped to develop.

MTAS or a tale of evidence heedless medicine
Unsatisfactory response by Ms Patterson
12 October 2007
Previous Rapid Response Next Rapid Response Top
Peter von Kaehne,
General Practitioner
Scotland

Send response to journal:
Re: Unsatisfactory response by Ms Patterson

Although there is over a century’s literature on selection methodologies, [...]


This could suggest that there are heaps and heaps of data available on the subject, that Ms Patterson's role was only one of sifting the abundant and overwhelming evidence and that the medical profession was grossly negligent in its previous blatant disregard of good science on the subject.

And yet, all but one quote in Ms Patterson's response appear to be self references.

What does this tell us?

While I am in no position to judge even remotely how close and how responsible Ms Patterson's outfit was, the response by Ms Patterson leaves me in little doubt that she was too close and had too much responsibility.

So, please leave us alone with your suggestion that you share the anger of the profession. Chances are, that you are a perfectly valid target for the anger of the profession. Your letter at least does not reassure me on that account.

Competing interests: None declared

MTAS or a tale of evidence heedless medicine
No defence
11 October 2007
Previous Rapid Response Next Rapid Response Top
ben dean,
sho
oxford

Send response to journal:
Re: No defence

Fiona Patterson is clearly attempting to distance herself from the complete and utter failure of MTAS 2007 with her above response that lists many references that are used as so called 'evidence'. The process that she had a large part in creating and forcing upon us was certainly not suitable for the selection of any trainees; irrespective of whether they were Foundation trainees, ST1s, ST9s or monkeys. I have not managed to find a single Foundation trainee who thinks that their selection process over recent years has been anything other than a load of politically correct hogwash.

The MTAS process and the use of white space questions were proven beyond any doubt to be rubbish of the highest order, and certainly not fit for use in any selection process. If Prof Patterson wants evidence, then I think the year 2007 provides an overwhelming quantity of evidence that should should force her to go back to the proverbial drawing board before inflicting any more of this upon unsuspecting juniors.

Undoubtedly Prof Patterson was only one of many of a dysfunctional heirarchy that was to blame, however she is a little naive if she thinks that she can talk her way out of any responsibility so easily. The future is indeed challenging and this is because so many people including Prof Patterson did so much to create a completely useless selection process last year. I suggest if this argument becomes about evidence, then the events of 2007 can provide more concrete evidence than any number of psychoeducationalist trials.

Competing interests: None declared

MTAS or a tale of evidence heedless medicine
Evidence heedless medicine
11 October 2007
Previous Rapid Response Next Rapid Response Top
John Sanderson,
Professor of Clinical Cardiology
B16 8AH

Send response to journal:
Re: Evidence heedless medicine

Belatedly I have just read Dr Nachev's brilliant analysis of the failure of MTAS. The lack of any experimental evidence is typical of most social or health economics policy. The contrast between the introduction of a new medicine and a new administrative 'therapy' or reorganization could not be greater. It appears that major NHS changes are introduced based on no-more than anecdotal evidence which would not be tolerated in the realm of medical therapeutics. Why are not the same standards applied and a proper controlled trial done of some of the proposed changes? It is not too difficult to envisage two differing policies being tested in two health care regions and the results tested after 5 years like in a clinical trial. The RCT has been one of the greatest steps in medicine and as we all know the results of a large clinical trial are often the exact opposite of the expected, obvious or 'logical' conclusion. Massive social and administrative changes are often introduced on a whim and a feeling that it must be right. The same mistakes are about to be made by Darzi and his collegues in the government with respect to general practice and polyclinics. No doubt millions of pounds more will be wasted on major stuctural changes with zero evidence of any actual benefit.

Competing interests: None declared

MTAS or a tale of evidence heedless medicine
Re: Selection methodology; fact, fiction and the future
11 October 2007
Previous Rapid Response Next Rapid Response Top
Alison L Gill,
ST2 Medicine
Harrogate District HospitalHG2

Send response to journal:
Re: Re: Selection methodology; fact, fiction and the future

Ms Patterson's points would be far more credible were it not for the fact that seven of her eight references were self-citations!

She accepts that pre-existing "selection practices in medicine have been effective", and that few "understand what a clinician does on a daily basis". What qualifications then does she have to make such recommendations and changes to medical selection and training?

She reports having "learned more from collaborating with the medical profession than from any other" - so why during this shambolic recruitment system, did she not think it necessary to consult with exactly those people that were to be affected by the changes?

Competing interests: MTAS applicant, four interviews, offered two posts, only to find months down the line that I should have been offered all four but due to a "system error" I was listed as having accepted an offer before I was even made aware of it!

MTAS or a tale of evidence heedless medicine
Re: Selection methodology; fact, fiction and the future
11 October 2007
Previous Rapid Response Next Rapid Response Top
Matthew J Daniels,
FTSTA ST2 CMT
Addenbrookes Hospital, CB2 0QQ

Send response to journal:
Re: Re: Selection methodology; fact, fiction and the future

In Professor Patterson statement is clear that her expectations for the process and the reality of its implementation were quite at odds.

Why then has it taken until October 2007 for these concerns to be voiced?

I recall one of the white box questions in the probity section - "Give a specific example of a time when you became aware that a clinical mistake had been made, either by you or someone else. How did you deal with this situation and how did your actions contribute to the outcome?"

As the Fidelio group have already reminded us; "All that is necessary for the triumph of evil is that good men do nothing."1.

1 Brown M et al The Lancet 2007; 369:967-968

Competing interests: Dr in training disillusioned by the whole process

MTAS or a tale of evidence heedless medicine
Re: MTAS or a tale of evidence heedless medicine
11 October 2007
Previous Rapid Response Next Rapid Response Top
Alison S Carr,
Deputy Postgraduate Dean, NHS Education South West (Peninsula Institute)
Plymouth PL6 8DH

Send response to journal:
Re: Re: MTAS or a tale of evidence heedless medicine

Dear Editor

I would like to correct some of the details that have been cited by Dr Nachev on the development of resources for recruitment and selection into specialty training in 2007. The author suggests that the criteria and procedure for selection in MTAS were principally designed by a handful of organisational Psychologists from Work Psychology Partnership and that the selection methods developed have never been used to select specialist trainees. Neither of these suggestions are correct.

Professor Fiona Patterson and her colleagues from Work Psychology Partnership have worked alongside the medical profession for over 12 years in helping develop recruitment and selection methodology for recruiting specialist trainees such as General Practitioners, Obstetricians, Paediatricians, and Surgeons. This team specialise in recruitment and selection methodology and have applied their knowledge base to medicine in liaison with specialists from the medical specialties. Work Psychology Partnership have worked with GPs for over ten years in developing the recruitment and selection processes used successfully for recruitment into general practice training. In addition, for several years they have worked developing and evaluating recruitment and selection pilots into surgery with the Royal College of Surgeons. In fact almost all of the research published on recruitment and selection into medical training has been published with Professor Fiona Patterson as one of the authors.

In this article, Dr Nachev remarks that every slide of the material prepared for the Department of Health he had seen was emblazoned with Work Psychology Partnership logo (www.mmc360.com/documents/ recruitment_to_specialist_training.pdf). In fact most of these slides were designed by myself in my role as Honorary Associate Dean for the National Recruitment and Selection Project 2007. In this role, I was one of three doctors who accompanied the methodology team on Deanery roadshows around the United Kingdom providing information for Deanery staff and trainers on the processes of recruitment and selection into specialty training proposed for 2007.

In addition, it must be stressed that the medical input to the recruitment and selection process was provided by doctors and that processes used were introduced with consultation of the Royal Colleges, Work Psychology Partnership acting as Consultants in recruitment and selection methodology. The criteria for recruitment and selection into Specialty Training, from which the methodology was developed, were those as laid down by the PMETB (http://www.pmetb.org.uk/index.php?id=456).

Competing interests: None declared

MTAS or a tale of evidence heedless medicine
More light less heat
11 October 2007
Previous Rapid Response Next Rapid Response Top
Frank R Smith,
Primary Care Taskforce Lead
South Central SHA Highcroft Winchester SO22 5DH

Send response to journal:
Re: More light less heat

The BMJ of the 22nd September has a number of pieces on medical training. The Editor has 'pondered the BMJ's coverage' but she should re-assess her sanctioning of Nachev's personal view as completely counter-productive to the debate, despite its tabloid appeal in playing to the masses of (deservedly)unhappy junior doctors. Selection science is not an oxymoron, and whilst longitudinal studies still need to be done, there is evidence building of the utility of different selection methods compared to the traditional CV and interview. The Tooke analysis of the events of 2007 is likely to identify some key learning points. The BMJ should aim for more light but not heat in this debate.

Competing interests: Have worked on developing selection for GP with Professor Patterson

PRACTICE:
Do all fractures need full immobilisation?
Glasziou (22 September 2007) [Full text] [PDF]
Do all fractures need full immobilisation?
Appropriate, no universal, referal please
11 October 2007
Previous Rapid Response Next Rapid Response Top
Paul P Glasziou,
general practitioner
Oxford, OX3 7LF

Send response to journal:
Re: Appropriate, no universal, referal please

I am pleased that no one has questioned the validity of the Liow trial or its applicability to the patient: the trial enrolled Mason 1 and 2 radial head fractures, and my patient had a "suspected" Mason 1 undisplaced fracture. The issues raised appear to concern which patients require referral from primary care, a goal of 100% "success", and the appropriate information resources doctors should use. I would like to discuss these in turn.
How should we decide who is managed in primary care and who in secondary care? One extreme that Dr McQueen seems to suggest is that "all conditions should ideally be reviewed by specialists" and GPs would simply decide which specialist every patient should see. An immediate problem would be the swamping of secondary care, and delays in treatment that would degrade rather than improve care. But even if we could massively increase secondary care capacity to allow referal of all patients, the resulting fragmented care would have undesirable consequences, particularly for patients with multiple conditions and for preventive care. This may partly explain why stronger primary care is related to better health outcomes[1]. Rather than every patient been seen by consultants, we would be best off with appropriate referal guidance. As a junior doctor, though I studied Apley's texts, I liked Patrick Browne's "Basic Facts of Fractures" because of its clear guidance about expertise needed to handle different injuries and fractures (using a * to **** system). Undisplaced radial head fractures, along with undisplaced clavilcular fracture, contused elbow, isolated fibula fracture, etc are one "*" and "... can be managed quite adequately by any doctor at his office with the minimum of equipment".
While I admire the sentiment of 100% success, this is an impossible "target". Primary and secondary care should work together to continually reduce error and poor outcomes, but we will never reach 100%. As the various reports on quality and safety suggest, secondary care is not error free either[2,3], and an overworked and overcrowded secondary care would be more prone to error. Wise use of our medical workforces’ diverse skills is necessary to give us the time to manage well.
Finally, the respondents appear not to be aware of how we currently answer, and don't answer, information needs in practice. Several studies suggest that most doctors information needs go unanswered, and when they are answered it is generally with readily available rather than the best information[4]. And searching clinicians poorly skilled in searching and appraisal can degrade rather than improve decisions[5]. Patients would be better served if clinicians better recognised their own information needs, and had the skills to identify and use the best available research evidence, and discuss this with colleagues in both primary and secondary care.
References
1. Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970-1998. Health Serv Res 2003: 831-65.
2. Experience of wrong site surgery and surgical marking practices among clinicians in the UK. Qual Saf Health Care. 2006 Oct;15(5):363-8.
3. Shaw R, Drever F, Hughes H, Osborn S, Williams S. Adverse events and near miss reporting in the NHS. Qual Saf Health Care. 2005 Aug;14(4):279-83.
4. Green ML, Ciampi MA, Ellis PJ. Residents' medical information needs in clinic: are they being met? Am J Med. 2000 Aug 15;109(3):218-23.
5. McKibbon KA, Fridsma DB. Effectiveness of clinician-selected electronic information resources for answering primary care physicians' information needs. J Am Med Inform Assoc. 2006 Nov-Dec;13(6):653-9.

Competing interests: None declared

PRACTICE:
Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control
Barnes (8 September 2007) [Full text] [PDF]
Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves...
A SMART choice for primary care asthma therapy ?
13 October 2007
Previous Rapid Response Next Rapid Response Top
Brian J Lipworth,
Consultant Chest Physician
Asthma and Allergy Research Group ,University of Dundee,and Tayside Centre for General Practice,
Catherine Jackson

Send response to journal:
Re: A SMART choice for primary care asthma therapy ?

Professor Barnes makes an apparently cogent argument for using SMART single flexible combination inhaler therapy as the preferred treatment for moderate to severe asthma .Unfortunately his arguments are likely to be rather biased due to the inherent flawed selection criteria used for inclusion into these clinical trials. This is because the SMART trials [and indeed other long acting beta2-agonist trials] selectively exclude patients who are non responders to formoterol, because inclusion requires patients to have demonstrable beta-2-adrenoceptor agonist reversibility .

There will always be a heterogeneous response to formoterol due to the predictable development of tolerance ,especially for protection against bronchoconstrictor stimuli ,which may in part be genetically determined [1] .In everyday clinical practice ,especially in primary care ,we do not commonly see such patients who have marked beta-2 agonist reversibility ,as seen in the clinical trials, so it is not possible to extrapolate the results of these studies to what happens out there in the real world .

The blanket prescribing of SMART to patients as advocated by Professor Barnes is a slippery slope ,unless perhaps one restricts using the SMART regimen to those who demonstrate beta-2 agonist reversibility ,which is unlikely to happen on a routine basis in the busy setting of primary care ,where most patients with asthma are treated in the UK . The other concern for primary care prescribing is that the routine use of SMART will inevitably creep back in the guidelines from step 3 to step 2 ,whereas most patients with mild to moderate disease can be adequately controlled on an optimised dose of inhaled steroid alone ,which is considerably cheaper .

References

1.Lipworth BLong-acting beta(2)-adrenoceptor agonists: a smart choice for asthma? Trends Pharmacol Sci. 2007 Jun;28(6):257-62. Epub 2007 Apr 26

Competing interests: BJL and the Asthma and Allergy Research Group has received payments for performing clinical trials ,educactional support ,equipment ,speaking and consulting from : AstraZeneca ,GlaxoSmithKline,Teva,Mundipharma,Nycomed,Cipla,Neolab,Schering ,Plough,Merck,Trinity-Chiesi,Innovata .

CLINICAL REVIEW:
Acute respiratory distress syndrome
Leaver and Evans (25 August 2007) [Full text] [PDF]
Acute respiratory distress syndrome
Should we use low tidal volume in all our ARDS patients?
12 October 2007
Previous Rapid Response Next Rapid Response Top
Eduardo M Svoren,
Senior Registrar In Anaesthesia
St Bartholomew Hospital,
Marcela Vizcaychipi

Send response to journal:
Re: Should we use low tidal volume in all our ARDS patients?

Dear Editor. We read with great interest the clinical review about Acute Respiratory Distress Syndrome (ARDS) published on 25th Aug 2007(1) and we found remarkably surprising the ventilatory strategy recommended by the authors, quoting the Network Trial as a landmark paper in mechanical ventilation (2). We would like to refresh that the Alliance for Human Research Protection (AHRP) has led the American National Institute of Health to suspend enrolment of patients in the Network Trial on grounds of legally invalid consent (most of the patients of the ARDSnet trial were enrolled without a legally effective consent) and also due to failure to minimize risk (the use of excessive tidal volume in the control group ignore previous trials suggesting that high tidal volumes have been associated with higher death rate) (3). In addition Peter Eichacker suggested in his meta-analysis that the used of low tidal volume is not associated with proven survival benefits (4).

Good experimental and clinical evidence support the concept that the use of high tidal volume in this group of patients may be detrimental by inducing and aggravating lung injury (5). However, we consider there is still not enough and conclusive clinical evidence to accept the use of tidal volume adjusted to 6 ml per kg of predicted body weight in all patients presenting in the intensive Care Unit with ARDS. Furthermore, this unconventional respiratory modality might potentially lead to harm (6,7,8,9). We would like to advocate a more conservative approach limiting plateau pressure between 28 and 32 cm of H20 as a more prudent ventilatory strategy until new evidence settle this controversy.

1- Susannah Leaver, Timothy Evans. Clinical Review .Acute Respiratory Distress Syndrome. BMJ 2007;335:389-94.

2- Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000;342:1301-8.

3- Amat o MB. Beneficial effect of the open lung approach with low distending pressure in acute respiratory distress syndrome. A prospective randomised study on mechanical ventilation. Am J of Resp and Crit Care Med 1998;152:1835-1846.

4- P Eichacker. Meta-Analysis of acute lung injury and acute respiratory distress syndrome. Trials testing low tidal volumes.Am J Resp Crit Care Med 2002;166:1510-1514.

5- Slusky AS.Lung injury caused by mechanical ventilation. Chest 1999;116:9s-15s.

6- Brochard L. Tidal volume reduction for ventilatory prevention of ventilatory induced lung injury in acute respiratory distress syndrome. Am J Resp Crit Care Med 1998;158:1831:38.

7- Brower RG. Prospective, randomised, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med1999;17:1492-98.

8- Stewart TE. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Eng J Med 1998;338:355-361.

9- Ricard JD. Are we really reducing tidal volume and should we? Am J Resp Crit Med 2003;167:2002-2003.

Competing interests: None declared

RESEARCH:
Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial
Montini et al. (25 August 2007) [Abstract] [Full text] [PDF]
Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled...
Response to Montini Article
12 October 2007
Previous Rapid Response Next Rapid Response Top
Alejandro Hoberman,
Professor of Pediatrics
Children's Hospital of Pittsburgh, 15213,
Ellen R. Wald

Send response to journal:
Re: Response to Montini Article

We were pleased to read the study by Montini and co-workers which has further substantiated our study regarding the effectiveness of using oral antimicrobials for the management of acute pyelonephritis in children.1 We congratulate them on enrolling this large cohort of children. The difference in proportion of girls vs boys among children in the two studies may well relate to the frequency of circumcision in the two populations. Our population studied in the US included relatively few uncircumcised boys; accordingly, the rate of UTI among boys in general will be reduced. The rate of circumcision in the Italian study is not cited. Conway et al evaluated electronic health record data from a network of 27 primary care practices; 543 (89%) of the 611 children aged 6 years or younger diagnosed with an initial UTI were female.2 The rate of reflux noted in our study (40%) is quite consistent with the results of numerous other investigations.3, 4 The differences in rates of scarring are quite interesting. Because we studied children less than 2 years of age, the threshold for evaluation for the presence of UTI may have been lower resulting in earlier diagnosis and treatment and therefore less scarring. This is perhaps reflected in the shorter time to defervescence and the lower rate of scarring – which is also consistent with more recent studies.5

Additional unanswered questions we have regarding the Montini study include: (1) the timing of entry is not clear: were children enrolled after the first sample of urine or after the second confirmatory urine was obtained?, (2) the assumption that children with initial negative DMSA scans had no reinfections during the ensuing year in order to assume that a negative initial scan results in a negative follow-up scan (88 and 89 children in the oral and parenteral treatment groups, respectively); (3) a relatively large proportion of children (20.3%) lost to follow-up, and (4) with regard to interpretation of DMSA renal scans, (a) whether any interobserver agreement was measured in preparation for or during the trial, (b) whether any standardization of interpretations by regions or extent, other than definitions of acute pyelonephritis and renal scarring were utilized.

References:

1. Montini G, Toffolo A, Zucchetta P, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. Br Med J 2007; 335:386.

2. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. Jama 2007;298(2):179-86.

3. Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999;103(4):e54.

4. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics 1999;103(4 Pt 1):843-52.

5. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117(3):626-32.

Competing interests: None declared

FEATURE:
Hyperactivity in children: the Gillberg affair
Gornall (25 August 2007) [Full text] [PDF]
Hyperactivity in children: the Gillberg affair
Assessment for the Swedish Research Council
12 October 2007
Previous Rapid Response Next Rapid Response Top
Denny H Vågerö,
Professor, director
Centre for Health Equity Studies, CHESS, Stockholm University/ Karolinska Institutet

Send response to journal:
Re: Assessment for the Swedish Research Council

Jonathan Gordall quotes me in his article. Allow me to clarify.

I was asked by the Swedish Research Council to review some of the critique against Gillberg, specifically the harsh critique against Gillberg's work formulated by Eva Kärfve in her book"Brain Ghosts" (available only in Swedish). My judgment (see below), as well as that of professor Ottoson, concerned what was written by Eva Kärfve and whether her critique of the Gillberg group was unfair and could be said to constitute scientific misconduct. We were not asked, and found no particular reason, to look into whether she was collaborating with the scientology church or not - in fact this is irrelevant to the primary conflict between Kärfve and Gillberg. Neither were we asked to, or did we, look into the events leading up to the destruction of Gillberg’s large data material. Both of these aspects are central in Gordall’s article and in the 22 (so far) rapid responses.

The reviews commissioned by the Swedish Research Council in 2006 have only been available in Swedish. I think they would help the reader of BMJ to understand the roots of the controversy and to move beyond the bitter accusations and counter-accusations. My review and that of professor Jan Otto Ottoson came to similar conclusions. Finally the Swedish Research Council followed our advice that Kärfve’s criticism should not be dismissed as scientific misconduct.

Below is my statement for the Swedish Research Council.

To the Swedish Research Council

I, the undersigned, have been requested by the Swedish Research Council to present my views on the Lund University communication of 26 March 2005 concerning the claim that Eva Kärfve had been guilty of scientific misconduct. A preliminary approach was made to me in the late autumn of 2005, and this was followed by a definite request in February 2006. The Lund University communication raises a number of issues. The Swedish Research Council, however, primarily wanted me to take a position on the question of whether Eva Kärfve’s research could be described as scientifically dishonest on the basis of three passages in her book Hjärnspöken (‘Brain Ghosts’) specified in the university communication.

My opinion on these three points is as follows:

1. Kärfve (page 15) writes that Gillberg and Landgren ignored or dismissed findings that indicated the relevance of social factors, such as social class or housing conditions, for minimal brain dysfunction (MBD). Is this claim misleading or untrue?

Gillberg discussed psychosocial conditions and social class in a number of different places in his doctoral thesis. He finds, for instance (page 103, table III), that social class, poor housing areas and rented flat accommodation are highly correlated to the MBD diagnosis. Similarly, the mother’s stress load is significantly correlated to the MBD diagnosis in the child. He nevertheless concludes (page 112) that “Social disadvantage is in itself not an etiological factor”.

This certainly looks like a dismissal.

The keywords in seeking to understand Gillberg’s conclusion are in itself. On page 112, he explains: “Social class, although in itself highly correlated to the MBD diagnosis, was not in any way a factor directly affecting the background variables studied.” Instead, the etiologically operative background factors to which weight is attached are for instance “prenatal non-optimal factors” and “hereditary non-optimality” etc. Gillberg appears to be arguing that since social class and housing area are not linked to these background factors, they cannot be of etiological interest. But if social class and housing area are highly correlated to MBD, despite not being correlated to variables such as “prenatal non- optimal factors”, a reasonable conclusion would instead seem to be that social class is an (‘upstream’) etiological factor that operates via some other mechanism than the ones discussed above. Thus an important discovery is left hanging in the air, without any interpretation.

Alternatively, social class may nevertheless have affected the factors grouped under the heading “prenatal non-optimal factors” (including for instance low weight at birth and premature birth) without such a link being detected in this particular study, targeting as it does a relatively limited number of persons (= low statistical power). In Sweden, low birth weight and premature birth were more common among working-class mothers and mothers with little education during this period. Gillberg himself notes in his thesis the relevance of low birth weight and “small for gestational age” as etiological factors for MBD (pages 110–111). Thus it would have been reasonable to expect that “prenatal non-optimal factors” would mediate the observed correlation from social class to MBD in Gillberg’s study. Here, too, an unanswered question is left hanging in the air.

The factors grouped under the heading of “hereditary non-optimality” also include some with a social content. Late puberty among older relatives is taken to be suboptimal heredity. But the age of entry into puberty has been shown to be highly differentiated by social class in all countries where the matter has been examined. This background factor, therefore, might equally well be interpreted as a social factor as an hereditary one.

Kärfve may be wrong to argue that Gillberg ignored the impact of social class and housing area on the development of neuropsychiatric diagnosis. She is right, however, to argue that he dismissed them as significant causal factors. Gillberg’s reasons for dismissing them are hardly convincing, at least not in light of our current knowledge in this area. Even if Gillberg had devoted greater attention to this issue, it goes almost without saying that a sociologically trained person would want to analyse this point in greater depth and to partly dispute it. Kärfve’s criticism in this respect cannot therefore be described as illegitimate.

2. Kärfve (pages 49–55) discusses what is termed the Mariestad study by Magnus Landgren, Christopher Gillberg et al. The study is included in Landgren’s thesis. Lund University’s communication asks for comments on what Kärfve says about this study on page 52 in her book. In describing the authors’ work, she talks about them “rummaging through old patient records”, accuses them of cynicism and urges that their work be rejected. Kärfve’s tone is bantering. Is she misleading, scientifically dishonest or propagating an untruth?

Kärfve comments on the fact that five children who were screened as positive and whose parents subsequently declined to take part in the clinicial study were nevertheless included in it. Landgren and his colleagues give the children neuropsychiatric diagnoses with the aid of patient records (“a thorough evaluation of all previous records and of the screening results” [page I:5 in Landgren’s thesis]). The diagnoses are given without the team having met the children. Examination of the records led to five children being given the following diagnoses: motor perception dysfunction, mental retardation, DAMP, ADHD, and in one case a combination of ADHD/DAMP.

This procedure contrasts sharply with the account of how other children in the study were given their diagnoses, namely through “…in- depth neurodevelopmental/neuropsychiatric assessment. This comprised a detailed history, psychiatric and neurodevelopmental examination, neuropsychological assessment and evaluation of speech and language performed by the author (ML), psychologists and speech therapists…. a medical, developmental and behavioural history was taken at interview with the parents, using a standardised interview schedule…etc.” (Page I:3 in Landgren’s thesis.)

Diagnosis setting and diagnosis criteria are one of the most controversial aspects of the Gillberg group’s research. There is good reason to critically discuss the way these five diagnoses were made. The study is a limited one, at least in terms of statistical ‘power’, and it is not clear to what extent the addition of these five diagnosed children to the other 58 diagnosed children has affected various conclusions in the study. The methodological problem is left unsolved. Landgren’s discussion fails to tackle the problem; instead, the mothers’ reluctance to take part in the study is seen as possible confirmation of the neuropsychiatric diagnosis given to the children. Nor is there any discussion of the ethical problem of including the five children in the study against their parents’ wishes.

I am of the opinion that Kärfve’s criticism on this point – despite the severe language it is couched in – is neither dishonest, untrue nor unreasonable.

3. Point 3 in the Lund University communication principally concerns pages 45–55 in Kärfve’s book. These sections mainly deal with how Gillberg’s and Landgren’s theses estimate the prevalence of MBD (Gillberg) and DAMP and other diagnoses (Landgren). Gillberg makes specific estimates of the prevalence in Sweden based on their studies. Kärfve is highly critical of how Gillberg’s prevalence estimate is strongly influenced by two cases that were transferred from the control group to the group with MBD. As a result, MBD prevalence among boys is estimated at almost 10 per cent. This illustrates how small changes in the material can have a major impact on estimates. Kärfve has similar objections to Landgren’s estimates.

Probably a more important problem concerning the estimation of prevalence of such neuropsychiatric diagnoses among children in Sweden is the extent to which the authors’ material is selected. Even if the intention is to base the study on the population as a whole, a step by step process occurs until those who are to take part in the study are finally selected. The selection covers such aspects as the researchers’ choice of study venue, whether the children attend preschool, parental decisions whether or not to take part in a survey, decisions by preschool staff whether or not to distribute the survey questionnaires, parental decisions as to whether their children should be clinically examined or not, and the researchers’ decisions whether to expand groups or move people between groups. It is by no means certain (especially in the case of the Göteborg study) that prevalence estimates are actually based on a sample of children that is representative of the child population in each venue, not to mention Sweden as a whole. A full discussion of possible bias in the estimation is needed. Nor have Landgren and Gillberg included any statistically calculated confidence intervals with their estimates. This is otherwise common practice, especially if working with representative samples. Thus it is difficult to express any opinion at all on the value of Gillberg’s estimation from 1981 that 7.1 per cent of Swedish children have MDB.

Viewed objectively, therefore, Kärfve’s criticism of what she calls Gillberg and Landgren’s neuropsychiatric mathematics is not particularly startling.

Conclusions

Lund University has asked for an assessment of certain passages in Eva Kärfve’s book, ‘Brain Ghosts’. Are they examples of scientific misconduct? Kärfve does not pursue any neuropsychiatric research of her own – in her book she makes no reference to publications of her own in this field – and can therefore hardly be accused of scientific misconduct in the sense of having invented her observations, falsified her findings or showing negligence in the presentation of her data. Original research – the base on which scientific knowledge is built – must of course be the area of activity subjected to the closest scrutiny, whether cheating or dishonesty is suspected or not.

In the present case, the question is whether Kärfve’s critique of research undertaken by others is dishonest. All three points raised in the Lund University communication concern Kärfve’s discussion of the Gillberg group’s research, not her own studies (in the same book) concerning the ideological roots of some of the ideas that both laypersons and professionally trained experts possess/have possessed concerning mental ill-health and its causes. Scientific critique should also be subject to scrutiny, of course, but can the same criteria be applied?

Scientific critique, whether strongly polemical or not, should in my opinion be considered a legitimate activity even when the person levelling the criticism does not primarily belong to the research community being criticised. Advancing one’s criticism outside academia, as part of the public discourse, is also legitimate. Normally, scientific critique helps improve the research in question. Research controversies, even when marred by irrelevancies, often generate new perspectives on old truths or unresolved scientific issues. In that sense, scientific critique is one of the conditions of research and a prerequisite for knowledge growth. Kärfve’s sociological expertise means that she is competent to assess various aspects (but not all) of the Gillberg group’s research. Research methodology and analyses of causal links are (or should be) essentially the same in all disciplines primarily concerned with studying human beings and human society. If they nevertheless differ, there is every reason to express oneself with care and to carefully encourage interdisciplinary understanding.

Kärfve’s book is largely a polemical publication of a general nature – primarily intended, perhaps, to influence the community at large and policymakers, and only as a secondary consideration addressing the specialised circle of people working scientifically with these matters. One might take the view that Kärfve is unnecessarily disputatious in tone, or sometimes goes a bit far, but writing a polemical publication on scientific issues that is partly or largely aimed at a general readership can hardly be equated with scientific misconduct. On the contrary, it is a time-honoured tradition in many scientific fields.

I believe it would be of benefit to the scientific discourse if Eva Kärfve were also to express her views precisely and scientifically in the sociological or medical science press. An unfortunate aspect of the conflict currently surrounding neuropsychiatry is that it risks drawing up unproductive battle lines between social scientists and the medical profession. Ranging the ‘biological’ against the ‘sociological’, or ‘biologism’ against ‘sociologism’, may be popular nowadays, but it is totally fruitless. Most biological processes are affected by people’s relations to one another, i.e. by society. Equally, social processes are affected by biology. If we are to understand how, we need a dialogue between disciplines. If the Swedish Research Council has a part to play in connection with the Kärfve-Gillberg conflict, it should be to promote such a dialogue and to prevent bloc-building and disciplinary trench warfare.

Some unique research material has been destroyed. The development of children’s mental health in modern Swedish society is in many ways a cause for concern. We need to bury the hatchets.

Stockholm, 20 March 2006

Denny Vågerö Professor, Member of the Royal Swedish Academy of Sciences

(Translation by Stephen Croall)

Competing interests: None declared

Hyperactivity in children: the Gillberg affair
Industry of Death?
12 October 2007
Previous Rapid Response Next Rapid Response Top
Vanna Beckman,
Free lance journalist and writer
Kungälv, Sweden

Send response to journal:
Re: Industry of Death?

Steven Rose uphelds at least two different professional roles – one as a basic neuroscientist and another one that is deeply involved in political and ideological struggles in fields not directly connected with his neuroscientific research. Unfortunately in his writings he often doesn’t keep these roles apart but appears with the authority of the all- knowing scientist also when struggling against the well established diagnosis of ADHD, what he regards as the excessive use of anti- depressants or everything that he includes under the heading of neurogenetic determinism.

Read for instance the chapter Explaining the brain, healing the mind? in his book “The 21st Century Brain. Explaining, mending and Manipulating the Mind” (2005) - and I think most people would join me in appointing Steven Rose a pronounced advocate for the anti-psychiatry camp. He devotes much space to the tragic cul-de-sacs of psychiatric practice like lobotomy and barbiturates, in a condescending tone ridicules the “so-called ‘evidence-based medicine’“ and the “bible of DSM”. Talking of SRRIs he stresses the suicide risk, the big money involved and Peter Breggin’s ideas that many psychiatric disturbances be caused by drugs. His picture of psychiatry is all black and sinister, without mentioning the considerable advances made during the last half century in the quest to alleviate the burden of mental conditions.

After having described what he calls the epidemic of depression and anxiety and the widened criteria for bipolar disease and schizophrenia he asks if it is “as some conspiracy theorists (such as the scientologists) suspect, a medicalising myth through which people are kept in thrall by a sinister psychiatric establishment?” (page 225). After finishing the book it is difficult not to draw the conclusion that his own answer must be in the positive. I have absolutely no suspicion that Steven Rose has direct relations to scientology, but nevertheless many of his themes coincide with the writings of Thomas Szasz, Peter Breggin and others in their rather homogeneous anti-psychiatric ideology whose most aggressive megaphone is the Church of Scientology with its DVD “Psychiatry – Industry of Death”.

Vanna Beckman,

freelance journalist and writer, Kungälv, Sweden

Competing interests: None declared

Competing interests: None declared

FEATURE:
Should we consider a boycott of Israeli academic institutions? No
Baum (21 July 2007) [Full text] [PDF]
Should we consider a boycott of Israeli academic institutions? No
Professor Baum still not answering and handing over to IMA
12 October 2007
Previous Rapid Response Next Rapid Response Top
Christopher J Burns-Cox,
consultant physician
Southend Farm,,
Wotton-under-Edge GLOS GL12 7PB

Send response to journal:
Re: Professor Baum still not answering and handing over to IMA

Yet again (October 4) the Professor has not responded to the facts in the reports from multiple Human Rights Organisations listed by Derek Summerfield.For an academic deliberately to ignore the evidence is strange indeed and suggests an attempt at denial. There is plenty of evidence of the disgrace of Israelis officially, purposefully and deliberately causing pain and suffering to Palestinian detainees - amongst others. The Israeli government has claimed that detainees are 'under constant medical supervision'.

In 2001 the BMA, a close friend of the IMA, published a handbook 'The Medical Profession and Human Rights'. It was written by its Human Rights steering group chaired by Professor Vivienne Nathanson. It includes a description of prolonged torture of a Palestinian detainee (p64) and states that the Israeli authorities use 'forms of pressure which might constitute torture or cruel and degrading treatment'. (Evidence obtained under torture is legally valid in Israel.) The book (p65) states that 'Israeli doctors examined detainees prior to interrogation to ensure they were fit enough to withstand the 'moderate physicial pressure'.

I can see it is very difficult for a Zionist and for the IMA to accept that the Israeli government and Medical Association is involved in torturing and that denial is one, albeit disgraceful, way of coping but the facts are thoroughly out in the public domain.

Seek ye the truth where it may be found, Professsor Baum, but I am not sure the IMA is its sacred repository!

The IMA in its response is still in denial and veers off the point in an oft repeated fabrication that Palestinian ambulances frequently carry bombs and suicide bombers. In fact the Jewish American Medical Project has recently analysed these stories and found only one instance and the truth of that was debatable. The Jerusalem Post agreed with this report! What is undoubtedly true and carefully documented is the slaughter of Palestinian health workers and attacks on ambulances being shot at and many staff injured and killed.

Appended to the IMA response are two letters. The first is to Officials including the Chief Medical Officer and Chief Military Prosecutor of 'the territories'asking for a meeting and reassurance about the state of health of the Palestinians. This interest might be reassuring but why was the letter sent as recently as July 12 2007? Is this merely belated or sent as a tactic in panic? It is tragic that those Israeli doctors who do chose to practice according to internationally acceptable ethical standards are led by an organisation that betrays them so openly. All the Palestinian health organisations and Physicians for Human Rights Israel have called for the IMA to be boycotted and a group of UK doctors agrees. We have waited too long already. It is in the interests of Israelis, their doctors and of the Palestinians that the IMA be boycotted to help it come to its senses. It would be a surprise, but a wonderful one, if the BMA acted according to its official principles and assisted in this.

Competing interests: None declared

Should we consider a boycott of Israeli academic institutions? No
Professor Baum, as a Doctor: please treat the cause not the symptom
12 October 2007
Previous Rapid Response Next Rapid Response Top
Mamdouh EL-Adl,
Consultant Psychiatrist
Princess Marina Hospital, Upton, Northampton NN5 6UH

Send response to journal:
Re: Professor Baum, as a Doctor: please treat the cause not the symptom

Editor It seems that Professor Baum did not pay any attention to treating the cause & decided to limit his article to looking for a symptomatic treatment!

1.Israel is a democracy! 2.Israel is multicultural! 3.If you want to boycott, do not use USB! 4.Some Jews established a charity in Gaza to treat Palestinian children. 5.Israeli Doctors treat Palestinian & Israeli patients equally! 6.Boycott will harm peace initiative!

1.Israel is a democracy: Does any democracy have the right to occupy the land of another nation? Of course no. Thus being democratic does not give Israel the right to occupy Palestine. However the elected Israeli Prime Minister has a different view. The Israeli plan:- "I believed, and to this day still believe, in our people’s eternal and historic right to this entire land." Ehud Olmert, Israeli Prime Minister, to the US House of Representatives, June 2006 [1} Does Professor Michael Baum support this view?

2.Israel is multicultural! [2] - Israel is the only country that considers religion as the nationality of its citizens i.e. any Jew is entitled to be an Israeli citizen anytime s/he wants. It is important to know that the numbers of Palestinians in Israel (Muslim & Christians) is in progressive decline due to the aggressive Israeli policies supported by the Israeli military machine.

-Israel was established in 1948 based on the claim that the Jews lived in this land 5000 years ago & have the right to return to it. On the other hand the Palestinians who were driven out of their lands by the Zionist armed groups since 1948 are denied the right to return back to their homes. The Israeli government denies the Palestinians the right to return after 50 years, while the Zionists claim the right to occupy Palestine 5000 years later.

-Yuri Avneri, an Israeli peace activist stated in one of his articles: “When tanks overrun cars, destroy houses, topple electricity poles, open water pipes, leave behind them thousands of homeless people and cause children to drink from puddles in the street, it causes terrible hatred. A Palestinian child, who sees all this with his eyes, becomes the suicide-bomber of tomorrow”[3]. Is this what could be considered by Professor Baum multicultural!

3.Professor Baum stated in his article: “If you want to boycott, do not use USB, .. because it is made in Israel!!” [2]. The right question should be: Is their a reason to boycott? If the boycott is for supporting human rights, should we sacrifice supporting human rights to use the Israeli made USB!! 4.Some Jews established a charity in Gaza to treat Palestinian children! Does this justify the Israeli occupation of Palestine & the violation of basic human rights of the Palestinians? Establishing this charity neither justifies the occupation nor reduces the size of the crimes that have been committed & still continued against the Palestinians since the establishment of the Zionist state.

5. Israeli doctors treat Palestinian & Jewish patients equally [2].

- Is equity in care a basic human right or a privilege offered to Palestinian patients by the kind hearted occupying power? Under the IV Geneva Convention, the occupying power is responsible for the people under its occupation. So the healthcare of all Palestinians living under the Israeli occupation is the responsibility of Israel. Lastly, it should be said: Do not treat the Palestinians when ill if treating them justifies to you occupying their land.

Doctors are taught in the medical school to treat the cause & not to limit their care to treating the symptom. However Professor M Baum in his article did not condemn the Israeli occupation of Palestine & its disastrous impact on the life of all Palestinians. Instead Professor Baum was only minded with highlighting the help offered by Israeli doctors to relief some of the Palestinian misery. Michael Baum should have bravely stated that the route cause of the problem is Occupation & should have called for the end of this occupation. However he has chosen not to treat the cause, Why?!.

I wonder: Would Professor Baum pass a medical student in the exam if this medical student focused only on the symptomatic treatment.

6.Boycott will harm peace initiative! Where is peace? Can we have Peace without Justice?!!!!! Dani Filc, chairperson PHR Israel PHR Israel stated: When extreme poverty results from the deliberate destruction of the economic infrastructure, we would expect them to make their stand clear as to the dire results on Palestinians’ health and demand the end of this policy. When faced with a humanitarian crisis, we would expect them to lead a struggle for changing the policy that causes it, at least regarding the health issues [4].

Dr M EL-Adl Consultant Psychiatrist

References

1. Halpin D, Educate How? www.bmj/rapidresponse, accessed on 10.08.07 2. Baum M, Should we consider a boycott of Israeli academic institutions? No. BMJ 2007;335(7611):125 (21 July), doi:10.1136/bmj.39266.509016.AD 3. Avneri Y, wais.stanford.edu/Israel/israel_viewofyury42002.html - 5k, accessed on 10.08.07 4. Dani Filc, Do we take ethics seriously? www.bmj/rapid response, 11.05.07/accessed on 10.08.07

Competing interests: None declared

RESEARCH:
Implementing the NHS information technology programme: qualitative study of progress in acute trusts
Hendy et al. (30 June 2007) [Abstract] [Full text] [PDF]
Implementing the NHS information technology programme: qualitative study of progress...
Unexpected benefit of Choose and Book
11 October 2007
Previous Rapid Response Next Rapid Response Top
Paul E Shannon,
locum consultant anaesthetist
Doncaster Royal Infirmary, DN2 5LT

Send response to journal:
Re: Unexpected benefit of Choose and Book

As an ex-National Clinical Lead for Choose and Book, I am well aware of the benefits that the system provides for clinicians. One unanticipated benefit is the avoidance of using Royal Mail during strike action! Outpatient appointments and referral letters are made electronically and so are not subject to the vagaries of the postal system. Let's hope that this strike action will encourage colleagues to look afresh at Choose and Book.

Similarly, letters to the editor of the BMJ are unaffected when utilising Rapid Responses. However, who knows if readers will see this before the strike ends?

Competing interests: None declared

EDITORIALS:
Diabetic ketoacidosis
Dhatariya (23 June 2007) [Full text] [PDF]
Diabetic ketoacidosis
Would Normal Saline be licensed today?
11 October 2007
Previous Rapid Response Next Rapid Response Top
Nicholas Levy,
Consultant in Anaesthesia and Critical Care
West Suffolk Hospital, IP33 2QZ,
Dr Stuart Lowe

Send response to journal:
Re: Would Normal Saline be licensed today?

Dear Sir

We read with interest the recent editorial by Dhaetariya(1). In his editorial, the use of Hartmann’s solution is bought into question and most of the physiological arguments are eloquently rebuked in the ensuring rapid response correspondence.

One of his most contentious comments is that there is unlikely to be a randomised study between normal saline and Hartmann’s solution due to the potential dangers of Hartmann’s solution. This comment is highly provocative as it suggests that those professionals who treat their diabetic patients with Hartmann’s solution are essentially being negligent, and as the ensuring correspondence shows there are a number of intensivists who choose to use Hartmann’s as part of the fluid regime to resuscitate patients with diabetic ketoacidosis (DKA).

Dr Dhaetariya questions the validity of use of Hartmann’s solution, which whilst we agree is not the perfect solution, we do believe is superior to normal saline, and we would like to question whether normal saline would ever be licensed now, if it was to be developed in the 21st century.

The pre-clinical studies would show that it does not maintain electrical or mechanical activity of isolated muscle preparations (2,3). In fact in 1901 in his seminal paper Harvey Cushing called saline ‘poisonous ’(2).

The phase 1 studies would show when normal saline is administered to healthy volunteers they subjectively complain of bloatedness, confusion, stomach cramps and essentially feel unwell. Objectively they develop a severe hyperchloraemic acidosis and retain the excess saline and fluid for a longer period than when compared to Hartmann’s solution.(4,5)

The Phase 2 studies, and there have been 3 randomised controlled studies comparing the administration of normal saline and balanced solution in high risk patients , again would not support the continued development of normal saline (6,7,8). In fact, 2 of the 3 studies were prematurely halted due to the excess morbidity in what was subsequently discovered to be the normal saline cohort.(6,8)

In summary, we reject the concept that it is potentially dangerous to administer Hartmann’s in preference to normal saline in patients with DKA, and we would welcome a study to find the solution to this contentious area (Pun intended).

1. Dhatariya KK. Diabetic Ketoacidosis. BMJ 2007; 334: 1284-5.

2. Cushing H. Concerning the poisonous effect of pure sodium chloride solutions upon the nerve-muscle preparation. Am J Physiol.1901; 6: 77-90

3. Howell W. An analysis of the sodium, potassium, and calcium salts of the blood on the automatic contractions of heart muscle. Am J Physiol.1901; 6: 181-206

4. Williams EL,et al. The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999;88:999–1003.

5. Reid F, Lobo DN, et al. (Ab)normal saline and physiological Hartmann’s solution: a randomized double-blind crossover study. Clin Sci (Lond) 2003;104:17–24.

6. O’Malley et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100: 1518-24. 7. Waters JH, et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001; 93: 817-22.

8. Wilkes NJ, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001;93:811–6.

Competing interests: None declared

RESEARCH:
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials
Walter et al. (10 March 2007) [Abstract] [Full text] [PDF]
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis...
Importance of calculation of absorbed dose in radioiodine treatment in patients pre-treated with antithyroid drugs
12 October 2007
Previous Rapid Response  Top
Gertrud Berg,
ass professor
Department of Oncology, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden

Send response to journal:
Re: Importance of calculation of absorbed dose in radioiodine treatment in patients pre-treated with antithyroid drugs

There is a disagreement about the influence of antithyroid drugs on radioiodine treatment. In the systematic review and meta-analysis of randomised controlled trials it was concluded that antithyroid drugs increase rates of failure and reduce rate of hypothyroidism if they are given in the week before or after radioiodine treatment (Walter et al 2007). I believe that one explanation for failure is the fact that antithyroid drugs simply affects the uptake and residence time of radioiodine. There is a risk in these cases that the thyroid receives a smaller absorbed dose from radioiodine if dose calculation including estimation of effective half-life of the radioiodine is not performed. If a dose calculation is performed, the outcome will be the same in patients treated with antithyroid drugs as in those without pre-treatment.

In Sweden the authorities recommend to use individual dose calculations for radioiodine treatment of patients with hyperthyroidism. We have thus for many years used a protocol where a test dose is given in order to calculate the amount of radioactivity (MBq) needed to obtain the absorbed dose (Gy) aimed at. We have shown that when we aim at an absorbed dose of 120 Gy we only have a failure of 7 % (Berg et al 96 b). The individual dose calculation takes into account the thyroid volume, the iodine uptake after 24 hours and the effective half -life of the radioiodine. We have reported about the special significance of the effective half-life (residence time of the radioisotope) in these measurements (Berg 1996a). We thus showed that the effective half-life can vary between 2 and 8 days where the mean half-life for patients with Graves’ disease was 5.3 days without pre medication with antithyroid drugs whereas patients with medication up to 7 days before treatment had a mean effective half-life of 4.4%. Thus if the half-life is not considered it is likely that the patients with prior antithyroid drugs will receive a lower absorbed dose than prescribed. The shorter period without medication the more impact on the half-life can be expected.

One explanation for the reduced half-life is that antithyroid drugs reduce the protein binding of iodine to thyroglobulin at the apical part of the thyrocytes. The radioiodine will thus reside shorter in the gland.

We often see a high uptake and a short half-life in patients with prior antithyroid drug treatment. It is our experience however that when an individual dose calculation is performed the treatment failure is in the same order for patients with and without prior medication. If individual dose calculation is not performed and standard activities are used it is likely that patients with prior antithyroid drugs receive a lower absorbed dose to the thyroid than wanted. A dose of eg 90 Gy is simply more unlikely to cure than the aimed dose of 120 Gy.

Berg G, Michanek A, Holmberg E, Nyström E. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow up study. J Int Med 1996; 239:165-71.

Berg G, Michanek A, Holmberg E, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 1996; 37: 228-32

Competing interests: None declared